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Dead Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein 9 (dCas9) is a 
catalytically dead Cas9 nuclease. It can be used in conjunction with a SunTag epitope array to recruit 
multiple copies of the transcriptional activator Viral Protein 64 (VP64) to any target gene, therefore 
increasing its expression. The system was initially developed in human cells and was shown to induce 
an up to 50-fold increase in gene expression. The aim of this study was to translate the technology 
into bread wheat, which is a vital global crop. SunTag constructs optimised for use in wheat were 
transiently and stably transformed into wheat protoplasts and plants respectively. The transcription, 
translation and interaction of these constructs were verified, although the results suggested they were 
weakly expressed or were deleterious in wheat. RNA sequencing (RNA-seq) analysis showed that 
SunTag could be used in protoplasts to increase expression of an exogenous target by 1.77-fold, 
however, no upregulation was detected when an endogenous gene was targeted. This study shows 
that the SunTag system can be implemented in wheat, however further development is necessary for 
it to become a useful tool. There are additional experiments which should be conducted to more 
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CHAPTER 1: INTRODUCTION  
1.1 CRISPR/Cas9  
Clustered regularly interspaced short palindromic repeats (CRISPRs) were first observed in 
Escherichia coli by Ishino et al. in 1987. Around 40% of bacteria and 90% of archaea contain CRISPRs 
as part of their adaptive immune systems (Makarova et al., 2011). Since their discovery, CRISPRs have 
been harnessed and modified for gene editing, resulting in a relatively quick and low-cost system 
known as CRISPR/Cas9 (CRISPR-associated protein 9) (Beneke et al., 2017; Kotwica-Rolinska et al., 
2019).  
There are two components to the CRISPR/Cas9 gene-editing system: the Cas9 nuclease and single 
guide RNA (sgRNA). The choice of Cas9 nuclease is important, as each demonstrates variable levels of 
on- and off-target activity. On-target activity, also known as editing efficiency, is defined as the 
percentage of target cells transformed with Cas9 in which mutations are observed in the target DNA 
(Raitskin et al., 2019). The specificity of Cas9 nucleases, which determines off-target activity, is also of 
vital importance as low specificity can cause a high rate of unintended mutations (Raitskin et al., 2019). 
Streptococcus pyogenes Cas9 (SpCas9) is the most commonly used nuclease variant, although it has 
been suggested that this isn’t the optimum variant for gene editing purposes (Gilbert et al., 2013b); 
for instance, SaCas9 from Staphylococcus aureus has been shown to have significantly greater 
efficiency compared to SpCas9 when targeting a synthetic tobacco (Nicotiana benthamiana) PDS1 
gene (Raitskin et al., 2019). Additionally, an engineered ‘enhanced specificity’ variant of SpCas9 has 
been released which has been shown to have reduced off-target effects in human cells 
(Slaymaker et al., 2016).  
CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA) molecules were originally used to 
guide the Cas9 protein to a complementary target genomic DNA (gDNA) sequence. crRNA and 
tracrRNA molecules are now frequently combined as a chimeric sgRNA molecule (Jinek et al., 2012), 
further simplifying the system. sgRNAs contain a 20bp sequence that is complementary to the target 
gDNA sequence directly upstream of a protospacer adjacent motif (PAM). Every Cas9 variant has a 
different PAM sequence, for instance, the PAM for spCas9 is NGG (where N is any nucleotide) 
(Graham & Root, 2015). The sgRNA forms a complex with Cas9, guiding the nuclease to the 20bp gDNA 
target sequence where it introduces a double-strand break (DSB).  
There are two possible pathways once the DSB has been created by the Cas9 nuclease, as detailed in 
Figure 1.1. Non-homologous end joining (NHEJ) is an error-prone method of repairing DSBs mediated 





mutations (Hsu et al., 2014). This phenomenon has been harnessed to knock-out (silence) genes of 
interest. Alternatively, homology-directed repair (HDR) can be used to introduce exogenous genes. 
Donor DNA is designed with ‘homology arms’ complementary to target gDNA (Zhang et al., 2017). 
When it is inserted into the target cell it is used as a template when the DSB is repaired, so inserting 
the donor DNA. 
This novel technique has revolutionised genomics since it was first applied as a gene-editing tool in 
mammalian cells in 2012 (Jinek et al., 2012). Despite some similarities to zinc finger nucleases and 
TALENs (Transcription Activator-Like Effector Nucleases), which have been used for gene editing since 
1996 and 2011 respectively (DeFrancesco, 2011; Kim et al., 1996), CRISPR/Cas9 has several advantages 
over either technique. The most significant of these are its adaptability and affordability 
(Larson et al., 2013). Whereas previous technologies have required complex redesign steps and 
Figure 1.1: The basic CRISPR/Cas9 gene-editing mechanism. There are two gene editing 
pathways once a double-strand break has been created: non-homologous end-joining 






lengthy subsequent validation for novel targets (Carroll et al., 2006; Cermak et al., 2011), CRISPR/Cas9 
requires only a change in the sgRNA inserted; sgRNAs are comparatively cheap and easy to design. 
This flexibility creates the possibility of multiplexing sgRNAs (using multiple sgRNAs in the same 
transformation) to either improve cleaving efficiency at a single gene or to target multiple genes 
concurrently.  
CRISPR is increasingly the tool of choice to interrogate gene function through generating knock-out 
mutants and analysing the mutant phenotype (Wang et al., 2014b; Wang et al., 2018). This 
methodology can also be utilised in genome-wide loss-of-function genetic screens, as shown in a 2014 
study by Wang et al. (2014a) in human cell lines. CRISPR/Cas9 avoids many disadvantages associated 
with previous screening techniques such as small interfering RNAs (siRNAs) (Wang et al., 2014a). The 
results of siRNA screens have been questioned as a result of significant off-target effects 
(Qiu et al., 2005; Taylor & Woodcock, 2015).  
The first CRISPR-edited commercial crop (a browning-resistant button mushroom (Agaricus bisporus)) 
was approved by the US government in 2016 (Waltz, 2016), illustrating how far the technology has 
advanced and been accepted by the wider public in a relatively short period of time.  
1.2 CRISPR ACTIVATION 
The original CRISPR gene-editing system has been modified several times to unlock its full potential. 
This has included using alternative Cas9 nucleases such as Cas12a (also known as Cpf1) which creates 
a staggered DSB via a T-rich PAM (Zetsche et al., 2015). Furthermore, the system has been adapted to 
use dead Cas9 (dCas9), a catalytically ‘dead’ Cas9 variant with two point mutations: D10A in the RuvC1 
nuclease domain and H841A in the HNH nuclease domain (Qi et al., 2013). These single nucleotide 
polymorphisms (SNPs) convey undetectable endonuclease activity. dCas9 was originally developed as 
an alternative knock-down technique that works by physically interfering with transcription via steric 
hindrance, a technique known as CRISPR interference (CRISPRi) (Larson et al., 2013; Qi et al., 2013).  
However, in the paper that first described CRISPRi, the potential of using dCas9 as a “flexible scaffold 
for directing diverse regulatory machinery to specific sites in the genome” (Qi et al., 2013) was noted.  
This dCas9 system relies upon either fusing or recruiting effector domains to the dCas9 construct. 
Effector domains are the ‘regulatory machinery’ (Qi et al., 2013) mentioned previously, which affect 
gene expression through their effects on epigenetic states as well as transcription (Frietze & Farnham, 
2011).  
Epigenetic modifications are heritable traits, independent of the DNA sequence, that affect gene 





expression can be altered. Chromatin structure affects the accessibility of genes to transcriptional 
machinery; heterochromatin has a dense structure and is transcriptionally inactive, while euchromatin 
is the more ‘open’ transcriptionally active form (Handy et al., 2011). Histone proteins, which form an 
integral part of chromatin, can also be modified, chiefly via acetylation which generally increases gene 
expression (Handy et al., 2011). Histone acetylation has been induced by dCas9-p300 
(Hilton et al., 2015) and dCas9-HAT fusions (Cheng et al., 2016), so increasing gene expression. The 
addition of a methyl group to the fifth carbon of cytosines in CpG dinucleotide sequences is a common 
epigenetic modification which silences the gene involved (Handy et al., 2011). Specific DNA 
methylation has been induced using dCas9-TET1 fusions (Xu et al., 2016) which decrease methylation 
(so increasing gene expression), as well as dCas9-DNMT3A fusions which increase methylation (so 
decreasing gene expression) (Vojta et al., 2016). Some effector domains have multiple mechanisms by 
which they induce epigenetic modifications and therefore modify gene expression. For instance, 
Gilbert et al. (2013b; 2014) fused the Krüppel-associated box (KRAB) domain from Kox1 to dCas9, 
which was shown to strongly repress target genes by inducing DNA methylation, histone 
deacetylation, histone methylation, the formation of heterochromatin, as well as steric hindrance by 
dCas9 itself (Gilbert et al., 2014; Ying et al., 2015).  
Transcriptional activation domains (TADs) can be fused to dCas9 to increase gene expression. These 
can act by either interacting with transcriptional machinery directly or by interacting with endogenous 
transcription factors (Frietze & Farnham, 2011). The uses of CRISPR-targeted effector domains have 
only been partially explored; it is a rapidly expanding area of research (Figure 1.2). Examples of 
dCas9-TAD fusions that have been tested include dCas9-p65, dCas9-Rta and dCas9-Viral Protein 64 
(VP64), of which dCas9-VP64 is the most used (Chavez et al., 2015; Li et al., 2017). VP64 is a tetramer 
of Viral Protein 16 (VP16), a transcription factor originating from the herpes simplex virus type 1 
(Hirai et al., 2010). It interacts with multiple basal transcription factors (Kobayashi et al., 1995; 
Lin et al., 1991; Xiao et al., 1994; Zhu et al., 1994), the Mediator complex (Ito et al., 1999; 
Mittler et al., 2003), as well as the cofactor PC4 (Ge & Roeder, 1994). It additionally recruits histone 
acetyltransferases, indirectly altering the epigenetic state of genes.  
Gilbert et al. (2013b) fused dCas9 to several different effector domains including VP64, inducing 
targeted gene activation in human (Homo sapiens) and yeast (Saccharomyces cerevisiae) cells. This 
technique went on to be known as CRISPR activation, or CRISPRa. dCas9-transcriptional activator 
fusion proteins have quickly become the ‘standard’ technique used in CRISPRa, and have been used 
in a wide variety of organisms such as E. coli (Bikard et al., 2013), tobacco (Piatek et al., 2015) and 
human cells (Perez-Pinera et al., 2013). Despite their popularity, dCas9-VP64 fusions frequently 





Second-generation systems have been developed to induce greater gene activation than simple 
protein fusions.  
In early studies an increase in the level of activation was achieved by tiling multiple sgRNAs targeted 
to a single promoter (Perez-Pinera et al., 2013), however, the need for more than one sgRNA per 
target may cause issues related to the scalability of the CRISPRa system, thereby limiting its potential 
in overexpression screens (Konermann et al., 2015). Therefore, other solutions have been sought. 
Second-generation systems most frequently utilise effector domains other than VP64, or increase the 
number of effector domains recruited to the target sequence. Examples of optimised effector domains 
include VPR (a VP64-p65-Rta fusion), which has been shown to increase gene expression up to 
320-times more potently than VP64 alone in human cells (Chavez et al., 2015), and TV (six copies of 
the TALE TAD motif from Xanthomonas oryzae fused to VP128), which showed up to 100-times greater 
gene upregulation in rice (Oryza spp.) compared to VP64 (Li et al., 2017). One limitation is that the 
most potent effector domain varies according to the target species, and possibly according to the 
target gene. For instance, while dCas9-VPR has been shown to upregulate human genes up to 
20,000-fold (Chavez et al., 2015), a comparatively modest 46-fold increase has been observed when 
using dCas9-TV (Li et al., 2017). Therefore, it is important to undertake a comparative study of effector 
molecules in each target species to ensure the most potent transcriptional upregulation is achieved.  
Figure 1.2: The number of publications per year resulting from a search for the topic “dCas9” 
































Direct fusions of high numbers of effector domains are not practical due to the corresponding increase 
in protein size and the issues this causes when generating transformation plasmids 
(Tanenbaum et al., 2014). Also, using multiple copies of VP64 (such as VP192 or VP256) decreases 
gene activation due to reduced protein production and subsequent protein stability (Li et al., 2017). 
Therefore, more complex systems are necessary to increase the number of effector domains recruited 
to a target promoter; these can be broadly classified into those which amplify the signal by recruiting 
multiple effector domain copies using the sgRNA molecule, or an epitope array fused to dCas9.  
sgRNA 2.0 is a system in which multiple effector domains are recruited to a target by MS2 aptamers 
bound to the sgRNA molecule. This system, developed by Konermann et al. (2015), involves recruiting 
various effector domains to the same target. VP64, p65 and Heat shock factor 1 (HSF1) proved to be 
the most potent combination of transcriptional upregulators showing a 105-fold median improvement 
in upregulation compared to dCas9-VP64 across 12 genes (Konermann et al., 2015). This specific 
combination was named ‘synergistic activation mediator’ (‘SAM’) (Konermann et al., 2015). The study 
also illustrated that SAM shows highly specific gene activation with low levels of off-target activity 
(Konermann et al., 2015). Furthermore, the SAM system was used to create a ‘genome-scale gene 
activation screen’ in A375 melanoma cells to identify genes that confer BRAF inhibitor resistance 
(Konermann et al., 2015). The same group has since carried out an additional CRISPRa screen with 
sgRNAs targeted to long non-coding RNAs (as opposed to protein-coding genes) to identify additional 
BRAF inhibitor candidate genes (Joung et al., 2017).  
As stated previously, an epitope array can be used as an alternative to the sgRNA molecule to recruit 
multiple effector domains and therefore amplify the gene activation signal. SunTag is one such system 
(Tanenbaum et al., 2014).   
1.3 THE SUNTAG SYSTEM 
The study described in this thesis is based upon the groundwork laid by Tanenbaum et al. (2014) in 
their paper titled “A Protein-Tagging System for Signal Amplification in Gene Expression and 
Fluorescence Imaging”. The paper, cited 455 times as of 18th February 2020 (Clarivate Analytics, 
2020b), reported the development of a system called ‘SunTag’ (Tanenbaum et al., 2014). It involves 
the use of an antibody epitope array bound to dCas9 which recruits numerous copies of a single-chain 
antibody (ScFv). The ScFv can then be attached to another protein, for instance, Green Fluorescent 
Protein (GFP) (Tanenbaum et al., 2014). The system was named for the brightness of the fluorescent 
tags it could produce after SUperNova stellar explosions (Tanenbaum et al., 2014). This system can be 





molecules to several cellular targets such as the plasma membrane; it was shown that a single SunTag 
complex is sufficient for fluorescent labelling (Tanenbaum et al., 2014).  
The group behind this work subsequently realised that this tool could be used to improve the 
dCas9-VP64 CRISPRa system. They fused a SunTag General Control Nonderepressible 4 (GCN4) epitope 
array to dCas9 and designed a VP64 ScFv which would bind to the GCN4 epitope, a system compared 
against the ‘classic’ dCas9-VP64 fusion protein design in Figure 1.3. In this case, 10 VP64 effector 
domains were recruited to a target promoter in contrast to the 24 GFP molecules recruited to targets 
for fluorescent imaging (Tanenbaum et al., 2014). Although this theoretically amplifies the activation 
signal to a lesser extent, Tanenbaum et al. (2014) found that SunTag24x and SunTag10x induced similar 
levels of gene activation. SunTag10x produced more consistent results, so was preferentially used for 
gene activation purposes.  
This system has since been successfully implemented in multiple organisms such as human, mouse 
(Mus musculus) and fly (Drosophila melanogaster) cells (Chavez et al., 2016), as well as into plants 
Figure 1.3: A comparison of two common CRISPRa techniques. A) The ‘classic’ dCas9-VP64 
fusion protein, contrasted with B) the SunTag system where multiple VP64 ScFvs bind to an 
epitope array fused to a dCas9 protein. SunTag induces significantly higher levels of 
transcription than dCas9-VP64 (Tanenbaum et al., 2014). Reprinted from Cell, 159, 
Tanenbaum et al., A protein-tagging system for signal amplification in gene expression and 








such as Arabidopsis thaliana (Papikian et al., 2019). These are generally model organisms, so a logical 
next step is to translate this technology into organisms of economic importance, including crop species 
such as wheat.  
1.4 EVOLUTIONARY HISTORY OF WHEAT 
Hexaploid bread wheat (Triticum aestivum) is an allopolyploid resulting from multiple hybridisation 
events between closely related species. It contains three genomes: A, B, and D. A suggested model of 
the hybridisation events that occurred during the evolution of T. aestivum is shown in Figure 1.4.  
It is generally agreed that wheat cultivation began around 10,000 years ago during the Neolithic 
revolution (Shewry, 2009). There is also some consensus on the identity of the diploid progenitors of 
the three T. aestivum genomes. Based on cytogenetic and repetitive sequence analysis the A genome 
progenitor is thought to have been Triticum urartu, a close relative of Triticum monococcum (einkorn 
wheat) (Dvořák et al., 1993; Glémin et al., 2019; Huang et al., 2002). The origin of the B genome is less 
certain, as an exact progenitor species is yet to be identified. An undiscovered species closely related 
to Aegilops speltoides is the most likely candidate given the similarities between the T. aestivum B 
Figure 1.4: Model of the evolutionary history of bread wheat (Triticum aestivum; AABBDD. 
The chromosomal composition of each species is displayed within the circles. From IWGSC 





genome and A. speltoides S genome (Glémin et al., 2019). However, some groups have suggested that 
there are multiple parental Aegilops progenitors of the B genome and so it is of polyphyletic origin 
(El Baidouri et al., 2017). A phylogenetic analysis of all diploid Triticeae species and a study based upon 
RNA sequencing (RNA-seq) data both support this multi-parental hypothesis (Petersen et al., 2006; 
Miki et al., 2019). Although it has been established that Aegilops tauschii is the D genome progenitor 
(Glémin et al., 2019; Petersen et al., 2006), the origin of the D genome lineage more generally is the 
source of significant controversy (El Baidouri et al., 2017). Marcussen et al. (2014) proposed a 
hypothesis where the D genome lineage arose via a single homoploid hybrid speciation event between 
the A and B genome lineages ~5.5 million years ago (Marcussen et al., 2014; Sandve et al., 2015). 
Li et al. (2015a; 2015b) subsequently proposed a more complex scenario involving multiple 
hybridisation events during the origins of the D genome. Studies have since been published in support 
of both hypotheses; one using amplicon sequencing of nuclear loci supported the Li et al. complex 
hybridisation hypothesis (Glémin et al., 2019), while another using transcriptome data supported the 
Marcussen et al. single hybridisation event hypothesis (Huynh et al., 2019). The origin of wheat is still 
a contentious issue.  
The evolutionary history of wheat is relevant to this project due to the effect that polyploidy has on 
epigenetic states and gene expression. A tripling of gene copy number should theoretically lead to a 
three-fold increase in gene expression (Comai, 2005). However, this is not always the case, possibly as 
a result of regulatory factors which do not increase in concentration according to ploidy level, or due 
to epigenetic resetting (Comai, 2005). This was exemplified in a northern blot study on monoploid, 
diploid, triploid and tetraploid maize (Zea mays) plants; gene expression was found to be mostly 
proportional to ploidy level, however, there were some exceptions where the inverse was observed 
(Guo et al., 1996). Polyploidy can also introduce epigenetic instability (Comai, 2005). Approximately 
2-2.5% of wheat genes have been estimated to have been epigenetically affected by hybridisation and 
polyploidisation, including regulatory changes and altered DNA methylation patterns (Comai, 2005). 
Polyploidy adds another level of complexity when implementing a system to induce specific gene 
expression in wheat, due to the effects it has on gene expression and epigenetic states. It also provides 
the option of targeting a single homeologue or all three.  
1.5 WHEAT BREEDING PROSPECTS 
Since it was first cultivated, hundreds of wheat varieties have been bred for numerous desirable traits 
to satisfy the growing demand for greater wheat yields. There are currently 585 wheat varieties 
registered on the EU database (European Commission, 2019). However, there has only been one 





maize and eight for rice (International Service for the Acquisition of Agri-Biotech Applications, 2019); 
it has been described as “an orphan among genetically modified (GM) crops” (Wulff & Dhugga, 2018). 
It is a vital crop, contributing 20% of calories consumed by humans globally 
(Food and Agriculture Organisation of the United Nations (FAO), 2017). In a move that demonstrates 
the importance placed on wheat as a crop, several global initiatives have recently been launched that 
aim to fund and coordinate wheat research. These include the G20-led Wheat Initiative 
(Wheat Initiative, 2016), as well as the BBSRC-funded Designing Future Wheat Institute Strategic 
Programme (Designing Future Wheat, 2020). As a major food source, wheat will play a significant role 
in ensuring future food security. It is also of political importance, with the increase in wheat prices in 
2007-8 being attributed to significant civil unrest, including contributing to the Arab Spring 
(Shiferaw et al., 2013).  
The human population is expected to continue growing and reach 11.8 billion by 2100 
(United Nations: Department of Economic and Social Affairs: Population Division, 2017); this will 
require food production to increase by 2-3% per year (Hawkesford et al., 2013). However, since the 
green revolution of 1966-1985 (Pingali, 2012), wheat yields have increased by an average of just 1.6% 
per year (FAO, 2017); lower increases than those observed over the same period in other cereal crops 
(Figure 1.5).  
There are several reasons for the low rate of increase in wheat yields. One is the well-documented 
lack of genetic diversity in elite modern varieties due to the bottleneck caused by domestication and 
intensive breeding efforts (Reif et al., 2005). This lack of diversity results in “genetic vulnerability” 
(Reif et al., 2005) to pests and disease and reduces the number of useful candidate alleles for 
crossbreeding. Climate change is predicted to disproportionately affect wheat compared to other 
major crops due to both its biology and current growing patterns (Tebaldi & Lobell, 2018). This trend 
has already been observed with a 15% decrease in potential yield estimated to have occurred in Russia 
from 1980-2008 due to climate change (Lobell et al., 2011). Based on Paris Agreement targets for 
long-term temperature increases (United Nations Framework Convention On Climate Change, 2015), 
wheat is predicted to see a 3.6% yield decrease by 2100, although this will likely be significantly offset 
by an increase in CO2 levels (Tebaldi & Lobell, 2018). 
Additionally, there are issues with the crossbreeding techniques traditionally used to introduce 
beneficial alleles. They are time- and resource-intensive due to wheat’s long generation time of 
4-5 months (Wulff & Dhugga, 2018). Problems with sexual incompatibility and linkage drag have also 





This evidence suggests that significant advances must be made to reach the required 2-3% annual 
increase in global yield (Hawkesford et al., 2013). CRISPR technology may result in significant 
improvements in yield through its applications to both fundamental science and crop breeding. 
1.6 CRISPRa IN WHEAT 
Translating tools such as CRISPRa into wheat is of vital importance due to the threats to wheat 
production described above. As a result of the complexity of its hexaploid genome and the fact it is a 
non-model organism, there has until recently been a lack of knowledge concerning this important crop 
species. The rate of progress has been rapid, with the landmark release of a reference genome in 2018 
(IWGSC, 2018). However, there are still significant improvements to be made, as shown by the release 
of an improved version of the reference genome just over a year later (IWGSC, 2019).  
CRISPR/Cas9 editing technology was first used in wheat in 2013 to knockout the TaMLO (Mildew 
resistance locus O) gene (Shan et al., 2013), a mutation which has been shown to confer powdery 
mildew resistance when all three homeologs are knocked-out (Wang et al., 2014b). Subsequent 
studies have used the technology to investigate putative grain weight genes (Zhang et al., 2018) as 
well as generate low-gluten wheat lines (Sánchez-León et al., 2018). Improvements have also been 
made to the technology itself, including delivery of the Cas9 and sgRNA constructs by 
Figure 1.5: Global maize (Zea mays), rice (Oryza spp.) and wheat (Triticum spp.) yields from 
























Agrobacterium tumefaciens-mediated methods as opposed to particle bombardment 
(Zhang et al., 2019). Agrobacterium tumefaciens-mediated transformation has been shown to reduce 
the occurrence of transgene silencing (Dai et al., 2001) as well as the number of transformed plants 
necessary to create a stably transformed line, although it does require a greater number of 
generations (Zhang et al., 2019). CRISPR technology has already been implemented as an effective 
technique in wheat, and there is huge potential to do the same with CRISPRa. Potential applications 
include genome-wide screens, gene function interrogation, and specific gene regulation via inducible 
systems. These are all valuable techniques which can be used to increase the level of basic knowledge 
for wheat, which will benefit breeding efforts immeasurably. This knowledge could be used to 
effectively target traditional crossbreeding efforts. Additionally, dependant on the future regulatory 
situation, CRISPRa could be used to directly create new wheat varieties with a variety of beneficial 
traits.  
1.7 PROJECT AIMS 
The broad aim of this research project is to create a system where specific gene expression can be 
induced in wheat using the SunTag system. This can be broken down into several parts: 
1. Implement transient and stable expression of a modified SunTag system in wheat cells and 
plants 
2. Verify that the dCas9-SunTagx10 and VP64-ScFv SunTag constructs are present in wheat cells 
and plants, and are expressing the corresponding mRNA and proteins. Verify that these 
SunTag proteins are interacting 
3. Induce specific gene expression of both inserted and endogenous genes, and quantify any 
changes in gene expression 
The methods used to achieve these aims are described in Chapter 2.  Aims 1 and 2 are broadly 
addressed in Chapter 3. In Chapter 4 I will describe how I assessed whether the third aim was achieved 
or not. Chapter 5 contains a discussion relating to the project as a whole, including its weaknesses, 
the impact of this study on the research area, as well as further work to be undertaken. 
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CHAPTER 2: MATERIALS AND METHODS 
All chemicals used were supplied by Sigma-Aldrich Corporation (St. Louis, MO, USA) unless otherwise 
stated. 
2.1 TRANSFORMATION CONSTRUCTS 
For the SunTag system to function, two proteins are required: dCas9-SunTagx10 and VP64-ScFv. The 
constructs used in this study were based on the plasmids published by Tanenbaum et al. (2014) 
(Addgene IDs 60904 and 60903). Various alterations were made to these constructs by Professor Keith 
Edwards (University of Bristol; Bristol, UK) to optimise them for use in wheat.  
Figure 2.1 contains schematic representations of the constructs used throughout this study.  
Figure 2.1: Schematic representation of the wheat-optimised A) dCas9-SunTagx10 and B) VP64-ScFv 
constructs used throughout this study. ubi1 represents the maize ubiquitin1 promoter region. NLS 
stands for nuclear localisation signal; the constructs contain NLSs from simian vacuolating virus 40 
(SV40) and human T-cell leukaemia virus 1 (Rex). HA represents a human influenza hemagglutinin tag. 
10x GCN4_v4 represents 10 copies of a 19 amino acid region of the General Control Nonderepressible 
protein 4 (GCN4) from S. cerevisiae  (Harmansa & Affolter, 2018). P2A is a self-cleaving motif from 
porcine teschovirus-1. sfGFP represents superfolder green fluorescent protein (Pédelacq et al., 2006). 
The histone 2B leader sequence is a nuclear localisation sequence from A. thaliana. ScFv represents a 
single chain variable fragment specific to the GCN4 epitope. VP64 represents a tetramer of the VP16 
(Viral Protein 16) activation domain from the herpes simplex virus. GB1 is the protein G B1 
solubilisation domain from Streptococcus sp.. The NOS terminator represents the A. tumefaciens 





2.2 TRANSIENT TRANSFORMATION 
2.2.1 Transformation Plasmids 
Figures A.1, A.2, and A.4 contain maps of the plasmids used for transient protoplast transformation. 
The constructs outlined in Figure 2.1 were ligated into separate Gateway™ pENTR™4 dual selection 
plasmid vectors (Invitrogen; Carlsbad, CA, USA) which were subsequently used to transform 
competent E. coli cells by Professor Keith Edwards (University of Bristol; Bristol, UK). The colonies were 
provided as 50% v/v ethylene glycol overnight culture solutions. The cultures were streaked on 
kanamycin (50 mg/ml) lysogeny broth (LB) (1% w/v tryptone, 0.5% w/v yeast extract, 1% w/v sodium 
chloride) agar plates and grown at 42 °C for approximately 16 h. The inoculated kanamycin plates were 
then stored long-term at 4 °C. A transformed E. coli colony was transferred to 50 ml LB containing 
25 µg/ml kanamycin and incubated for approximately 7 h at 37 °C, 200 RPM. This culture was 
transferred to 500 ml LB also containing 25 µg/ml kanamycin and incubated at 37 °C, 200 RPM for 
approximately 16 h. Plasmid DNA was subsequently isolated from this culture using the QIAGEN 
(Hilden, Germany) Plasmid Mega Kit according to the manufacturer’s instructions. The yield of plasmid 
DNA was quantified using a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific; 
Waltham, MA, USA) using the nucleic acid ‘DNA-50’ setting. Plasmids were stored in elution buffer 
(EB) (QIAGEN) at 1 µg/µl at −20 °C. 
All plasmid preparations underwent basic quality control using gel electrophoresis to detect possible 
nucleic acid contamination. An appropriate mass of agarose powder (Thermo Fisher Scientific) was 
added to TAE buffer (Thermo Fisher Scientific) to make a % w/v solution appropriate for the expected 
fragment sizes, based on a guide published by Thermo Fisher Scientific (Thermo Fisher Scientific, 
2012a). This was heated in a microwave until fully dissolved. The solution was allowed to cool slightly, 
and ethidium bromide was added to a final concentration of 1.69 µM. The solution was then stored 
at 65 °C until needed. Once the gel was poured and allowed to set, 10 µl of appropriately diluted 
sample and 3 µl of loading buffer (0.62 mM bromophenol blue, 752.49 mM glycerol) was loaded per 
lane, with 5-13 µl of 1 kb+ DNA ladder (New England Biolabs Inc.; Ipswich, MA, USA) in flanking lanes. 
Gels were run at 80-120 V until fragments were fully separated (1-3 h) and visualised using a GelDoc-It 
TS2 Imager (UVP, LLC; Upland, CA, USA). 
Sanger sequencing was used to confirm the plasmids contained the correct constructs. Polymerase 
chain reactions (PCRs) were carried out on the plasmid preparations to amplify the regions containing 
the SunTag constructs. Primer sequences are outlined in Table A.3. Per reaction, 20 pmol (2 µl) of 
forward primer, 20 pmol (2 µl) of reverse primer, 17 µl of sterile distilled water, 25 µl of HotStarTaq 





(Hamburg, Germany) Mastercycler® Nexus Gradient) conditions were as recommended by the master 
mix manufacturer. 
Sequencing reactions were carried out using the BigDye™ terminator v3.1 cycle sequencing kit 
(Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s instructions, except that 
the incubation step during cycle sequencing was carried out at 94 °C for 30 s as opposed to the 
recommended 96 °C for 1 min and, per sequencing reaction, 3 µl of purified PCR product and 3 µl of 
sterile distilled water were used. Primer sequences are outlined in Table A.3. 
Once the sequencing reaction had been carried out, the products underwent ethanol/EDTA 
precipitation. Per reaction product 10 µl sterile distilled water, 5 µl 125 mM EDTA (VWR International; 
Radnor, PA, USA) and 60 µl of 100% v/v ethanol (VWR International) were added and mixed by 
vortexing. The samples were centrifuged in an Eppendorf MiniSpin Plus at 11,337 x g for 10 min. The 
supernatant was removed, 100 µl 75% v/v ethanol was added, and the samples were centrifuged in 
an Eppendorf MiniSpin Plus at 11,337 x g for 10 min. The supernatant was removed by gentle 
aspiration, and the samples dried in a vacuum (Thermo Scientific (Waltham, MA, USA) Savant™ 
SPD1010 SpeedVac™) (vacuum level: 680 Pa) for 20 min. The pellet was resuspended in 15 µl Hi-Di™ 
formamide (Applied Biosystems) by pipetting up and down. The samples were loaded onto a 96-well 
plate, and all air bubbles removed by centrifuging on the ‘short’ setting of an Eppendorf 5804 R 
centrifuge. The plate was then loaded onto a 3500 Genetic Analyzer (Applied Biosystems). The 
resulting sequences were quality checked and trimmed using Chromas v2.6.6 
(Technelysium Pty Ltd, 2018) and aligned to the expected plasmid sequence using Sequencher v5.4.6 
(Gene Codes Corporation, 2017). 
2.2.2 Protoplast Isolation and PEG-Mediated Transformation 
The following wheat protoplasting protocol was based on that published by Shan et al. (2014). 
Approximately 20 shoots were cut using scissors from 9-12 d old Triticum aestivum cv. Cadenza 
seedlings grown using Levington Advance Seed and Modular F2 compost (Israel Chemicals Ltd.; 
Tel Aviv, Israel) at 25 °C in the dark. These were washed in distilled water and cut into 0.5-1 mm 
latitudinal strips using a razor blade. The shoots were incubated in plasmolysis buffer (600 mM 
D-mannitol) at room temperature in the dark for 10 min. The shoots were then transferred into 20 ml 
enzyme solution (50 mM potassium chloride (Mettler-Toledo International Inc.; Columbus, OH, USA), 
600 mM D-mannitol, 20 mM MES (Jena Bioscience; Jena, Germany), 1.5% w/v cellulase Onozuka RS 
from Trichoderma viride (SERVA Electrophoresis GmbH; Heidelberg, Germany), 0.75% w/v 
macerozyme R-10 from Rhizopus sp. (SERVA Electrophoresis GmbH), 10 mM calcium chloride 





was then vacuum infiltrated at room temperature in the dark in a UNIVAPO 150 vacuum concentrator 
(UniEquip Laborgerätebauund Vertriebs GmbH; Planegg, Germany) using a UNIJET II refrigerated 
aspirator (Uniequip Laborgerätebauund Vertriebs GmbH) for 30 min. Following this, the solution was 
incubated in the dark at 25 °C, 40 RPM for 4 h-overnight. After the incubation, 49.54 ml of room 
temperature W5 solution (126.16 mM calcium chloride, 155.43 mM sodium chloride (Invitrogen), 
100 mM MES, 5.37 mM potassium chloride) was added to the beaker and poured through a 40 µm 
sterile cell strainer (Fisher Scientific; Loughborough, UK) into two 50 ml falcon tubes. The samples 
were centrifuged at 80 x g in an Eppendorf 5804 R for 3 min at 4 °C. The supernatant was discarded, 
and the pellets were resuspended in 3 ml of ice-cold W5 solution and pooled in a single tube. A sample 
was removed for cell counting using a haemocytometer (Weber Scientific; Hamilton, NJ, USA) with an 
H-shaped moat under a light microscope (Olympus Corporation; Tokyo, Japan) at 10x magnification. 
The cells in four 0.1 µl squares were counted and the mean was used to estimate the total number of 
cells in the sample. The remaining protoplast cells were incubated on ice for 30 min, centrifuged at 
80 x g in an Eppendorf 5804 R for 1 min at 4 °C and the supernatant was removed. The protoplasts 
were gently resuspended in MMG (400 mM D-mannitol, 15 mM magnesium chloride (Invitrogen), 
4 mM MES) at a concentration of 1 x 106 cells per ml.  
Per transformation, 10 µg of plasmid, 100,000 protoplasts, and 110 µl PEG-CTS (200 mM D-mannitol, 
100 mM calcium chloride, 40% w/v polyethylene glycol (PEG) 4000 
(PanReac AppliChem ITW Reagents; Chicago, IL, USA)) was used. A GFP reporter plasmid (Figure A.1) 
was used as a positive control. The transformation reactions were incubated in the dark for 10 min at 
room temperature. The transformation was stopped by adding 880 µl room temperature W5 solution 
to each reaction and mixed by inverting the tubes. The samples were centrifuged at 81 x g in an 
Eppendorf MiniSpin Plus for 3 min at room temperature. The supernatant was removed, and the 
protoplasts were resuspended in 1.8 ml room temperature W5 solution. The protoplasts were 
incubated in the dark at 23 °C for 24-48 h. 
2.2.3 Protoplast Genotyping (Fluorescent Microscopy)  
A Leica Camera AG (Wetzlar, Germany) DM2000 microscope and Leica Camera AG SFL4000 
illumination source were used to identify transformed cells via the nuclear-targeted GFP both 
transformation constructs were tagged with. Excitation was set at 470 nm and 20%. Brightfield, GFP, 
and blue-green-red (BGR) filter cubes were used, and Leica application suite v4.4 software 





2.3 STABLE TRANSFORMATION 
2.3.1 Transformation by Particle Bombardment 
Transformation of hexaploid bread wheat cv. Cadenza callus was carried out using simultaneous 
particle bombardment using the constructs described in section 2.1. This was performed by Caroline 
Sparks (Rothamsted Research; Harpenden, UK). 
Experiments were mostly conducted using plants from the second generation (T2) B3598 R2 P1 line 
(referred to as B3598 hereafter). This line was shown by genotyping (as described in section 2.3.2) to 
be segregating for both SunTag constructs. Some studies were carried out on plants from the E3 (T3) 
line, which again was segregating for both SunTag constructs. All individuals were grown at 18 °C in 
16 h light, 8 h dark cycles. Levington Advance Seed and Modular F2 compost was used.  
2.3.2 Transformed Plant Line Genotyping 
Total DNA was isolated from B3598 and E3 leaf tissue harvested approximately two weeks after 
germination. Sections of leaf tissue approximately 2 cm in length were collected from all plants and 
placed inside 2 ml microcentrifuge tubes along with two 2 mm ball bearings and all samples were 
frozen for a minimum of 2 h at −80 °C. These samples were homogenised in a Geno/Grinder 2000 
(SPEX® SamplePrep; Metuchen, NJ, USA) at 1x rate for 3 min. Per sample 600 µl extraction buffer 
(0.1 M tris hydrochloride (pH 7.5), 50 mM EDTA (pH 8.0), 50 mM sodium chloride, 1.25% v/v SDS 
(Invitrogen)) preheated to 55 °C was added and shaken vigorously for a few seconds. The samples 
were incubated at 55 °C for 20 min, followed by 4 °C for 5 min. To each sample, 300 µl 6 M ammonium 
acetate (pre-chilled to 4 °C) was added. The tubes were again shaken vigorously for a few seconds. 
The samples were then incubated at 4 °C for 15 min. The samples were centrifuged at 14,104 x g in an 
Eppendorf MiniSpin Plus for 15 min at room temperature to pellet the precipitated proteins and other 
plant tissue. The supernatant was recovered (approximately 600 µl) and transferred to new 1.5 ml 
microcentrifuge tubes containing 360 µl isopropanol (Acros Organics BVBA; Geel, Belgium) and mixed 
by inverting the tubes several times. The samples were incubated at room temperature for 5 min and 
then centrifuged at 14,104 x g in an Eppendorf MiniSpin Plus for 15 min at room temperature to pellet 
the DNA. The supernatant was removed, and the DNA pellet was washed in 400 µl 70% v/v ethanol 
and centrifuged at 14,104 x g in an Eppendorf MiniSpin Plus for 5 min at room temperature. The 
supernatant was removed. The DNA pellet was resuspended in 100 µl EB. If it was difficult to 
resuspend the pellet, the sample was vortexed and heated to 50 °C for 10 min in a block heater and 
vortexed a second time. The concentration of the samples was quantified using a Nanodrop 1000 





To identify which plants contained construct DNA, PCR reactions were carried out as described in 
section 2.2.1. Gel electrophoresis was carried out on the PCR products as described in section 2.2.1. 
2.4 TRANSCRIPTOMIC ANALYSIS 
2.4.1 RNA Extraction 
Total RNA was isolated from protoplasts, B3598 leaf tissue, and E3 leaf tissue using a TRIzol™-based 
method. In the case of protoplasts, the cells were pelleted by centrifugation at 43 x g in an Eppendorf 
MiniSpin Plus for 2 min at room temperature and the supernatant was removed, being careful not to 
disturb the loose pellet. In the case of the leaf tissue extractions, 2 cm of leaf tissue was collected from 
all plants and placed inside 2 ml microcentrifuge tubes along with two ball bearings and all samples 
were frozen for a minimum of 2 h at −80 °C. These samples were subsequently homogenised in a 
Geno/Grinder 2000 at a 1x rate for 3 min. To each sample, 1 ml of TRIzol™ reagent (Invitrogen) was 
added and vortexed for 10 s. The samples were incubated at room temperature for 2-3 min, after 
which 200 µl of chloroform was added to each. The microcentrifuge tubes were shaken vigorously for 
15 s each and incubated at room temperature for 2-3 min. The samples were centrifuged at 1699 x g 
in an Eppendorf 5804 R for 20 min at 4 °C. For the remainder of the protocol, tubes were kept on ice. 
The colourless aqueous phase (approximately 1 ml) was transferred to new 15 ml falcon tubes and 
500 µl isopropanol was added. The samples were mixed by inverting the tubes and centrifuged at 
1699 x g in an Eppendorf 5804 R for 30 min at 4 °C and the supernatant was removed. To wash the 
pellet, 5 ml of 75% v/v ethanol was added, and the samples were centrifuged at 1699 x g in an 
Eppendorf 5804 R for 30 min at 4 °C. As much supernatant as possible was removed and the pellet 
was air-dried. The RNA pellet was finally resuspended in 100 µl of sterile distilled water (Invitrogen) 
by pipetting up and down. To eliminate any possible DNA contamination, 87.5 µl of the RNA sample 
was added to 10 µl RDD buffer (QIAGEN) and 2.5 µl DNAase I stock solution (Ambion, Inc; 
Austin, TX, USA) and incubated at room temperature for 30 min. RNA sample clean-up was then 
carried out using an RNeasy MinElute cleanup kit (QIAGEN) according to the manufacturer’s 
instructions, except for step 5 where the centrifugation time was reduced from 2 min to 60 s, and 
step 7 where 25 µl of RNAse-free water was used to elute the RNA instead of the recommended 14 µl. 
The concentration of the samples was quantified using a Nanodrop 1000 spectrophotometer using 
the nucleic acid ‘RNA-40’ setting. RNA samples were stored at −80 °C. 
2.4.2 RT-PCR 
Reverse transcriptase-PCRs (RT-PCRs) were carried out using a OneStep RT-PCR kit (QIAGEN) according 





the RT-PCR products was carried out as described in section 2.2.1. Sanger sequencing of the RT-PCR 
products was carried out as described in section 2.2.1. 
2.5 PROTEOMIC ANALYSIS 
2.5.1 Protein Extraction 
Total denatured protein was isolated from transformed protoplasts, B3598 leaf tissue, and E3 leaf 
tissue. In the case of protoplasts, the cells were pelleted by centrifugation at 43 x g in an Eppendorf 
MiniSpin Plus for 2 min at room temperature, and most of the supernatant was removed being careful 
not to disturb the loose pellet. In the case of the leaf tissue extractions, 2 cm of leaf tissue was 
collected from all plants and placed inside 2 ml microcentrifuge tubes along with two ball bearings 
and all samples were frozen for a minimum of 2 h at −80 °C. These samples were subsequently 
homogenised in a Geno/Grinder 2000 for 3 min. The homogenised plant material was suspended in 
1 ml ice-cold methanol with 0.2% v/v protease inhibitor cocktail, mixed by vortexing, and incubated 
at −20 °C for 5 min. The samples were centrifuged at 16,000 x g in an Eppendorf 5804 R for 5 min at 
4 °C and the supernatant was removed. This methanol wash was carried out a total of four times. The 
pellet was then resuspended in 1.5 ml acetone pre-chilled to −20 °C. The samples were incubated at 
−20 °C for 5 min, then centrifuged at 16,000 x g in an Eppendorf 5804 R for 5 min at 4 °C. The 
supernatant was removed, and the pellet was air-dried at room temperature for 10 min. The pellet 
was suspended in 200 µl of Reagent Type 4 Working Solution (Protein Extraction Reagent Type 4, 
1% v/v protease inhibitor cocktail) by vortexing for 15 min at room temperature. The samples were 
then centrifuged at 16,000 x g in an Eppendorf 5804 R for 30 min at room temperature. The 
supernatant was collected and transferred to a fresh 1.5 ml microcentrifuge tube. The concentration 
of the samples was quantified using a Bradford Assay (Bradford, 1976). All protein samples were 
diluted by a factor of 10 to ensure the buffer was compatible with the Bradford reagent. The Bradford 
assay was carried out according to the standard 3.1 ml assay protocol recommended by the Bradford 
reagent manufacturer. BSA was used to prepare protein standards. All assays were set up in triplicate. 
Protein concentration was quantified using the Nanodrop 1000 spectrophotometer using the 
‘Protein Bradford’ setting. Protein samples were stored at −20 °C. 
2.5.2 Preparation of Cell Lysate 
This protocol was based on protocols published by Abcam (2010) and Shan et al. (2014). Cell lysate 
was isolated from B3598 leaf tissue or protoplasts. In the case of protoplasts, the cells were pelleted 
by centrifugation at 12,000 x g in an Eppendorf MiniSpin Plus for 2 min at room temperature, and 
most of the supernatant was removed being careful not to disturb the loose pellet. The samples were 





sodium chloride, 1% v/v NP-40, 1% w/v sodium deoxycholate, 0.1% w/v SDS, 1% v/v protease inhibitor 
cocktail) on ice for 1 min. The samples were then incubated at 4 °C on a rocker for 30 min. Following 
this, the samples were centrifuged at 16,000 x g in an Eppendorf 5804 R for 20 min at 4 °C, and the 
supernatant was transferred to chilled 1.5 ml microcentrifuge tubes. 
In the case of the leaf tissue extractions, 2 cm of leaf tissue was collected from all plants and placed 
inside 2 ml microcentrifuge tubes along with two ball bearings and all samples were flash-frozen in 
liquid nitrogen and stored at −80 °C. These samples were subsequently homogenised in a 
Geno/Grinder 2000 at a 1x rate for 3 min. Per sample, 600 µl ice-cold RIPA buffer was added, mixed 
by vortexing, and incubated on a rocker for 2 h at 4 °C. The samples were centrifuged at 17,172 x g in 
an Eppendorf 5804 R for 20 min at 4 °C, and the supernatant was transferred to chilled 1.5 ml 
microcentrifuge tubes.  
The concentration of the samples was quantified using a Bradford Assay as described in section 2.5.1. 
Protein samples were stored at −20 °C. 
2.5.3 Protein Gel Electrophoresis 
To reduce the samples, 10 µl of protein sample was combined with 5 µl of NuPAGE™ LDS sample 
buffer (4x) (Invitrogen) and 1 µl of NuPAGE™ sample reducing agent (10x) (Invitrogen), then incubated 
at 70 °C for 10 min. The samples were allowed to cool to room temperature for 1-2 min. A NuPAGE™ 
3-8% tris-acetate protein gel (Invitrogen) was set up within an XCell SureLock™ Mini-Cell (Invitrogen). 
The running buffer used consisted of 5% v/v NuPAGE™ MOPS SDS running buffer (20x) (Invitrogen) 
and 0.1% v/v NuPAGE™ antioxidant (Invitrogen). The samples were loaded onto the gel along with 
15 µl of SeeBlue™ Plus 2 pre-stained protein standard (Invitrogen) in the first lane. Cas9 nuclease 
(New England BioLabs Inc.) was included as a positive control where possible. Each gel was 
electrophorized at 150 V for 45-60 min. 
2.5.4 Coomassie Blue Staining 
The electrophorized gel was removed from the plastic cassette and rinsed in distilled water. Enough 
SimplyBlue™ SafeStain Coomassie® G-250 stain (Invitrogen) was poured over the gel to cover it and it 
was incubated on a rocker for 1 h at room temperature. The gel was then rinsed with distilled water 
on a rocker for 30 min at room temperature 2-3 times. Finally, it was rinsed with distilled water 
overnight at room temperature and imaged using a Huawei Technologies Co., Ltd. (Shenzhen, China) 





2.5.5 Western Blotting 
Western blotting was carried out on electrophorized gels that had not undergone Coomassie blue 
staining. The transfer buffer consisted of 5% v/v NuPAGE transfer buffer (20x) (Invitrogen), 0.1% v/v 
NuPAGE™ antioxidant and 10% v/v methanol. Blotting pads from the XCell II™ blot module (Invitrogen) 
were saturated with transfer buffer. An Invitrolon™ 0.45 µm polyvinylidene fluoride (PVDF) 
membrane (Invitrogen) was pre-wet in methanol, rinsed in distilled water and submerged in transfer 
buffer for 2-3 min. The filter paper from the Invitrolon™ sandwich (Invitrogen) was submerged briefly 
in transfer buffer immediately before use. The electrophorized gel was removed from the plastic 
cassette, and the wells and lip were removed using a razor blade. The blot module was assembled 
according to the manufacturer’s instructions, placed in a SureLock™ Mini-Cell and filled with transfer 
buffer so the blotting pads were just covered. The outer chamber was filled with 650 ml of distilled 
water. The blot was run at 30 V (220-180 mA) for 60-90 min. The blot was probed using the 
WesternBreeze™ chemiluminescent kit (anti-rabbit) (Invitrogen) according to the manufacturer’s 
instructions. Cas9 antibody 3 (antibody details are contained in Table A.1) was used as the primary 
antibody at the manufacturer recommended concentration of 1 µg/ml. The blot was imaged with a 
Vilber Lourmat Sté (Collégien, France) Fusion Pulse using the ECLAppStd setting and the recommended 
exposure length. 
2.5.6 Co-Immunoprecipitation 
Cell lysate was obtained from plant B3598.6. Eight 2 cm pieces of leaf tissue were snap-frozen in 2 ml 
microcentrifuge tubes along with two ball bearings in liquid nitrogen. All samples were frozen for a 
minimum of 2 h at −80 °C then homogenised in a Geno/Grinder 2000 at 1x rate for 3 min. To each 
sample, 500 µl IP lysis/wash buffer from the Pierce™ co-immunoprecipitation kit (Thermo Scientific) 
was added and incubated on a rocker at 4 °C for 1 h. The samples were then centrifuged at 13,000 x g 
in an Eppendorf 5804 R for 10 min at 4 °C, and the supernatants were pooled in a single 5 ml 
microcentrifuge tube. Co-immunoprecipitation reactions were carried out using the Pierce™ 
co-immunoprecipitation kit according to the manufacturer’s instructions, including pre-clearing of the 
cell lysate and use of the conditioning buffer. Five sets of agarose beads were set up in spin columns 
with the following treatments: 
1. 75 µg Cas9 antibody 1 
2. 75 µg Cas9 antibody 2 
3. 75 µg Cas9 antibody 3 
4. Quenched antibody coupling resin (control 1) 





The protein concentration of the flow-through during the coupling reaction was measured using a 
Nanodrop 1000 spectrophotometer using the Protein A280 ‘1 Abs = 1 mg/ml’ setting. 
Co-immunoprecipitation reactions were carried out on 500 µl of pre-cleared cell lysate per spin 
column and the protein concentration of the eluted product was estimated using the Pierce™ BCA 
protein assay kit (Thermo Scientific) according to the manufacturer’s instructions, using the microplate 
procedure with a sample to working reagent (WR) ratio of 1:20. The Nanodrop 1000 
spectrophotometer was used to quantify protein concentration using the Protein BCA setting. 
2.5.7 Protein Digestion 
Protein digestion was carried out by Dr Kate Heesom (University of Bristol Proteomics Facility; 
Bristol, UK). The samples were reduced by adding 10 mM tris(2-carboxyethyl)phosphine (TCEP) and 
incubating at 55 °C for 1 h. The samples were then alkylated by incubating them with 18.75 mM 
iodoacetamide at room temperature for 30 min. Precipitation was carried out overnight by adding 
acetone to a final concentration of 85.71% v/v. Following this, the samples were centrifuged at 
8000 x g for 10 min and the supernatant was removed. Proteins were resuspended in 50 mM 
tetraethylammonium bromide (TEAB) and digested using 5% w/w grade trypsin (Promega UK; 
Southampton, UK) overnight at 37 °C. 
2.5.8 Liquid Chromatography-Mass Spectrometry (LC-MS) 
LC-MS was carried out by Dr Kate Heesom (University of Bristol Proteomics Facility; Bristol, UK) on 
peptides resulting from the protein digestion described in section 2.5.7. The peptides were desalted 
using a Sep Pak cartridge (Waters Corporation; Milford, MA, USA) according to the manufacturer’s 
instructions. The eluate from the Sep Pak cartridge was evaporated to dryness and resuspended in 
1% v/v formic acid. Fractionation was carried out on the peptides using an Ultimate 3000 nano-LC 
system and LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). The peptides were injected 
onto an Acclaim PepMap C18 nano-trap column (Thermo Scientific) and 0.5% v/v acetonitrile was used 
to wash the peptides. Peptides dissolved in 0.1% v/v formic acid were then resolved on a 
250 mm × 75 µm Acclaim PepMap C18 reverse phase analytical column (Thermo Scientific) over a 
150 min organic gradient. The concentration of solvent A (80% v/v acetonitrile in 0.1% v/v formic acid) 
in 0.1% v/v formic acid was altered over seven gradient segments (flow rate: 300 nl/min): 
1. 1-6% v/v solvent A over 1 min 
2. 6-15% v/v solvent A over 58 min 
3. 15-32% v/v solvent A over 58 min 
4. 32-40% v/v solvent A over 5 min 





6. 90% v/v solvent A for 6 min 
7. 90-1% v/v solvent A over 1 min 
Peptides were ionized by nano-electrospray using a stainless-steel emitter (Thermo Scientific) 
(voltage: 2.1 kV; internal diameter: 30 µm; capillary temperature: 250 °C). Tandem mass spectra were 
acquired using an LTQ-Orbitrap Velos mass spectrometer controlled by Xcalibur 2.1 software 
(Thermo Fisher Scientific, 2010). The settings used for mass spectrometry are detailed in the appendix 
(section A.4). 
The resulting raw data files were analysed using Proteome Discoverer software v1.4 
(Thermo Fisher Scientific, 2012b). Peptides detected in the samples were searched against the UniProt 
T. aestivum protein database (The UniProt Consortium, 2019) (142,582 amino acid sequences) in 
addition to dCas9-SunTagx10, VP64-ScFv and GFP protein sequences. The SEQUEST algorithm 
(Eng et al., 1994) was used for the search, and the parameters used are detailed in the appendix 
(section A.5) 
2.6 RNA-SEQ 
2.6.1 Sample Preparation 
Protoplasts were isolated from both wild-type cv. Cadenza (WT) and B3598.6 seedlings and 
transformed according to the protocol outlined in section 2.2.2. Details of the sgRNAs used are in 
Table A.2 and Figure 2.2. Six transformation treatments were applied to protoplasts in duplicate as 
outlined in Table 2.1. 
 
Treatment Protoplast genotype Transformation constructs 
1 (Negative control) WT None 
2 (ubi1 sgRNA negative control) WT ubi1 sgRNAs 1-4 
3 (Ppd-D1 sgRNA negative control) WT Ppd-D1 sgRNAs 1-5 
4 (SunTag negative control) B3598.6 None 
5 (ubi1 sgRNA experiment) B3598.6 ubi1 sgRNAs 1-4 
6 (Ppd-D1 sgRNA experiment) B3598.6 Ppd-D1 sgRNAs 1-5 
Table 2.1: Details of the treatments applied to batches of protoplasts for RNA-seq analysis. 
The protoplasts were transformed with pools of plasmids containing one of the appropriate 





Transformed protoplasts were incubated for 41 h at 23 °C, before total RNA was isolated using the 
protocol outlined in section 2.4.1, with the modification that the RNA was eluted from the QIAGEN 
clean-up column using 50 µl of RNase-free water. 
The RNA samples were quantified and quality assessed using a Nanodrop 1000 spectrophotometer as 
outlined in section 2.4.1, as well as an Agilent Technologies, Inc. (Santa Clara, CA, USA) TapeStation 
RNA screentape (carried out by Dr Christy Waterfall (University of Bristol Genomics Facility; 
Bristol, UK)). 
2.6.2 Library Preparation 
Library preparations were carried out by Dr Christy Waterfall (University of Bristol Genomics Facility; 
Bristol, UK) using the Illumina, Inc. (San Diego, CA, USA) TruSeq® Stranded mRNA library prep kit 
according to the manufacturer’s instructions. 270 ng of total RNA was used per library preparation. 
The cDNA libraries underwent quality control using an Agilent Technologies, Inc. TapeStation D1000 
ScreenTape® assay. 
2.6.3 Sequencing 
Sequencing was carried out by Dr Christy Waterfall (University of Bristol Genomics Facility; Bristol, UK). 
An Illumina, Inc. NextSeq500 system was used with the high output version 2.5 paired-end 2x75 bp kit 
according to the manufacturer’s instructions. NextSeq Control software v2.2.0 (Illumina, 2018) was 
used for run setup and monitoring. Primary analysis was conducted using Real Time Analysis v2.4.11 
software (Illumina, 2015). 96 FASTQ files were generated using BaseSpace (Illumina, 2019). 
Figure 2.2: The locations of the sgRNAs designed to target the wheat Ppd-D1 and maize ubi1 
promoters. The transcription and translation start sites are marked. The location in base pairs 





2.6.4 Data Analysis 
Data underwent initial quality-control using FastQC (Andrews, 2018). No trimming of the reads was 
deemed necessary. The FASTQ files were concatenated by Dr Alex Paterson 
(University of Bristol Genomics Facility; Bristol, UK) to create forward and reverse FASTQ files for each 
sample. These merged, un-trimmed FASTQ files were aligned to the IWGSC RefSeq v1.0 full genome 
sequence (IWGSC et al., 2018) using STAR RNA-seq aligner software (Dobin et al., 2013) by Dr Alex 
Paterson (University of Bristol Genomics Facility; Bristol, UK). Parameters used for alignments which 
were not set to the default value are listed in the section A.5. featureCounts (Liao et al., 2014) was 
used to assign these aligned reads to genomic features using the RefSeq v1.1 annotation 
(Unité de Recherche Génomique Info, 2019) by Dr Alex Paterson (University of Bristol 
Genomics Facility; Bristol, UK). Parameters used for alignments which were not set to the default value 
are listed in section A.6. DESeq2 (Love et al., 2014) was then used (with all parameters set to default 
values) to identify differential expression between samples using a negative binomial generalised 






CHAPTER 3: VERIFYING THE SYSTEM 
To establish that a SunTag system can induce specific gene expression in bread wheat, the presence 
of all SunTag system components must be verified. Secondly, the system must be put into practice 
and its impact on gene expression be assessed.  
This results chapter lays out the steps taken to verify that two of the essential elements of the SunTag 
CRISPRa system (dCas9-SunTagx10 and VP64-ScFv) can be transcribed, translated, and interact as 
predicted in vitro and in planta. This would satisfy the first and second aims of this project as set out 
in section 1.7. Theoretically, only the addition of sgRNAs (which have been previously expressed in 
wheat (Shan et al., 2014)) would be required to induce increased gene expression.  
3.1 TRANSFORMATION AND GENOTYPING 
3.1.1 Transformation Constructs 
As stated in section 2.1, the SunTag constructs published by Tanenbaum et al. (2014) were modified 
for use in wheat as they were originally designed for use in human cell lines. One major change was 
codon-optimisation according to codon usage bias in wheat. Several codons (groups of three bases) 
can encode a single amino acid; there are 61 possible codons (excluding the three stop codons) but 
only 20 amino acids (Behura & Severson, 2013). The genetic code is therefore described as 
‘degenerate’ (Crick et al., 1961). Where several codons encode a particular amino acid, it has been 
shown that organisms use synonymous codons at different frequencies. Codon usage can significantly 
affect gene expression, so when expressing an exogenous construct, it is important to use codons at 
the same frequency as the host organism (Plotkin & Kudla, 2011). For instance, when expressing 
interleukin-1 (IL1) and interleukin-2 (IL2) from bovine papillomavirus type 1 (BPV1) in Cos-1 cell 
cultures originating from Chlorocebus aethiops (African green monkey), codon-optimised constructs 
have been shown to produce 1000-fold more protein than wild-type constructs (Zhou et al., 1999). 
This reinforces the importance of codon optimisation when attempting to express constructs such as 
those used in the SunTag system. The maize ubiquitin1 (ubi1) promoter (a constitutive promoter 
suitable for use in monocots) was used to drive expression of the SunTag constructs instead of the 
simian vacuolating virus 40 (SV40) promoter (commonly used in mammalian cell lines). This alteration 
was necessary as promoters do not function in the same manner in all organisms, possibly due to 
differing endogenous promoter architectures (Yamamoto et al., 2007), or varying transcription factor 
availabilities (Biłas et al., 2016). ubi1 is a well-characterised promoter with generally strong expression 






3.1.2 Transient Expression in vitro 
In wheat protoplasts, transient expression of the modified SunTag constructs was accomplished via 
PEG-mediated plasmid transformation. Using a GFP reporter plasmid, a mean transformation rate of 
60% was achieved.  
dCas9-SunTagx10 (Figure A.2) and VP64-ScFv (Figure A.4) plasmids were used to transform protoplasts 
both separately and in co-transformations. As both constructs were GFP tagged, a transformation rate 
was able to be estimated via fluorescent microscopy (Figures 3.1 and A.5).  
Mean transformation rates for the SunTag constructs were lower than that of the GFP reporter 
control; 5.25% (number of studies (n) = 4) for dCas9-SunTagx10, 18.75% (n=4) for VP64-ScFv, and 
26.25% (n=4) for co-transformations. In co-transformation trials, it was not possible to determine 
whether protoplasts were transformed with only one or both plasmids as both carried GFP as a 
reporter gene. The reasons behind the lower transformation rate observed when using the SunTag 
plasmids compared to the GFP control plasmid are unclear; there are several possibilities. 
 
Figure 3.1: Image taken of protoplasts co-transformed with VP64-ScFv and dCas9-SunTagx10 
plasmids. The protoplasts were incubated for approximately 30 h. Excitation: 470 nm; 





If the transformation efficiency for the SunTag constructs was low, as indicated by fluorescent 
microscopy, it was unlikely to be due to the transformation technique used as the 60% mean 
transformation rate achieved using the GFP reporter plasmid is similar to that achieved by 
Shan et al. (2014). The dCas9-SunTagx10 plasmid, at over 10 kb, is much larger than either the 
VP64-ScFv or GFP plasmids which are both 6 kb. This may mean that the plasmid may be less likely to 
enter the protoplasts. It has been shown in E. coli that plasmid size is negatively correlated with 
transformation rate (Chan et al., 2002; Hanahan, 1983; Rehman et al., 2016). This may also be the 
case in wheat protoplasts. However, this would not explain the lower transformation rate observed 
for the VP64-ScFv plasmid, as it is just 25 bp larger than the GFP reporter plasmid.  
There is also the possibility that using the number of observable GFP signals as a proxy for 
transformation rate is inaccurate. The transformation rate may have been higher than estimated, 
however, despite cells containing construct DNA, some of the GFP tags may not have been present or 
have been too weak to have been observed. That is, transformed protoplasts may have shown low or 
undetectable levels of fluorescence. Whether a GFP signal is observed is partially dependent on the 
sensitivity of the detection system, including the microscope, camera and the eyes of the researcher. 
A more sensitive technique could be trialled, such as confocal microscopy; this technique generally 
generates images with a lower level of background (Fellers & Davidson, 2019) making any GFP signal 
easier to identify. Additionally, the excitation and capture parameters used in this study were not 
optimal. For instance, the excitation peak of sfGFP is 485 nm, while the wavelength used was 470 nm. 
Therefore, weaker GFP signals may have not been identified.  
However, there may have also been issues with the fluorescent protein pre-translation, during 
translation, or post-translation which led to a low concentration of GFP. Pre-translational issues would 
involve construct DNA or mRNA. The promoter may not express the constructs constitutively as 
expected. This is unlikely, as the ubi1 promoter has been used previously to successfully drive 
exogenous constructs in wheat (Wang et al., 2014b). However, there has been some evidence that 
ubi1 does not always act as a constitutive promoter; it is most active in “young, metabolically active 
tissues and in pollen grains” (Rooke et al., 2000). The protoplasts analysed in this study were isolated 
from 9-12 d old shoots. As one would assume that these tissues are metabolically active and so show 
constitutive ubi1 expression, it is unlikely that failure of the promoter accounts for low GFP expression. 
ubi1 activity could be increased through heat shock at the seedling stage, a strategy which has been 
shown to increase ubi1 activity in maize (Christensen et al., 1992). It has been previously observed 
that using the same promoter to express multiple transgenes can result in transcriptional gene 
silencing due to DNA methylation (Peremarti et al., 2010). Therefore, the system could be altered so 





Construct mRNA may not mature correctly in wheat, or it may experience a high level of degradation. 
Both incomplete mRNA maturation and mRNA degradation are processes that are used by host cells 
during the regulation of gene expression, and either may have been triggered by a specific motif in 
the SunTag constructs (Tourrière et al., 2002). There are no known reasons why this would occur, and 
this uncertainty is why the presence of correctly processed SunTag construct mRNA was investigated 
as described in section 3.2.  
Translational issues might account for the low number of GFP signals observed. Early termination can 
occur when release factors (proteins which govern translation termination) inaccurately identify sense 
codons (which encode an amino acid) as stop codons (Freistroffer et al., 2000). Early termination of 
protein translation would produce a truncated protein, almost certainly leading to a lack of GFP 
expression in the dCas9-SunTagx10 protein as the sfGFP is located at the C-terminus of the construct. 
However, there is a small possibility that translation was reinitiated later in the mRNA, therefore 
producing a GFP signal where the SunTag construct is not being completely synthesised. Termination 
and reinitiation of mRNA molecules has been shown to occur in mammalian expression vectors 
(Peabody & Berg, 1986). The sfGFP motif is near the N-terminus of the VP64-ScFv protein, so any early 
translation termination would not necessarily interfere with the GFP signal. This uncertainty 
necessitated an investigation into the presence of the SunTag proteins in transformed protoplasts and 
plants; this is explored in section 3.3.  
Finally, the SunTag proteins may be unstable and become degraded, although there is no known 
reason why the VP64-ScFv protein would be unstable in wheat. Other ScFv proteins have been shown 
to express in wheat (Stöger et al., 2000), however, there are no examples of either VP16, or its 
tetramer VP64, being successfully expressed in wheat. Therefore, it is not known whether this protein 
is stable in wheat cells. Constructs containing dCas9 have been expressed in wheat cells (Zong et al., 
2017), however, Tanenbaum et al. (2014) reported issues with dCas9-SunTagx10 protein stability during 
the initial development of the SunTag system. The group made efforts to increase the stability of the 
protein by decreasing the number of hydrophobic residues and increasing α-helical propensity 
(Tanenbaum et al., 2014). However, this may still pose an issue and lead to a low SunTag protein 
concentration, and therefore a difficult to detect GFP signal. It is important to note that the 
dCas9-SunTagx10 construct produces separate dCas9-SunTagx10 and GFP proteins. A porcine 
teschovirus-1 2A (P2A) motif separating dCas9-SunTagx10 and GFP induces a ribosome skipping 
mechanism whereby a glycyl-prolyl bond within the P2A amino acid sequence is ‘skipped’, so 
producing separate proteins (Donnelly et al., 2001). Therefore, dCas9-SunTagx10 protein instability 





Although these potential issues, before, during and after the translation process may mean that the 
transformation rate is higher than estimated, problems such as aberrant transcription or protein 
instability may result in a less efficient, or even non-functional CRISPRa system. If the number of GFP 
signals is an accurate proxy, and the expression level of the two SunTag constructs was low, this may 
not pose an issue as only a few dCas9-SunTagx10 molecules are needed for the system to function 
(Tanenbaum et al., 2014). Furthermore, the lead author of the paper suggested that a low level of 
SunTag construct expression is, in fact, optimal (personal communication). Therefore, the study was 
continued using these constructs despite the apparently low transformation rates, and further steps 
were taken to verify the presence of SunTag construct mRNA and protein.  
GFP signals were occasionally observed outside of the nucleus (Figure 3.2). This suggests that the 
protein may have been aggregating and was not being transported to the nucleus. The phenomenon 
was observed by Tanenbaum et al. (2014) during the development of the SunTag ScFv; the antibody 
was modified to reduce this phenomenon. These trials were conducted in human cells so further 
alterations may need to be made to optimise the system for wheat to eliminate the issue. Aggregation 
was not deemed to be an important issue, as it was also observed by Dr Mark Winfield 
(University of Bristol; Bristol, UK) in protoplasts in successful Cas9 editing trials 
(personal communication), and the phenomenon was observed in <0.5% of cells. Therefore, it was 
determined that the study should be continued despite this observation. In future, the structure of 
Figure 3.2: Image taken of a protoplast transformed with the dCas9-SunTagx10 plasmid. The 
red signal in the cytoplasm is chloroplast autofluorescence.  The protoplasts were incubated 
for approximately 46 h. Excitation: 470 nm; excitation intensity: 20%; magnification: 40x; 





the protein could be altered so that there is a lower likelihood of tertiary structures being formed. A 
stronger nuclear localisation sequence, or a higher number of nuclear localisation motifs, may also 
decrease the possibility of these accumulations.  
3.1.3 Stable Expression in planta 
Lines that stably express the SunTag constructs were generated by simultaneous particle 
bombardment using the same constructs as used in protoplasts, with the slight adjustment that 
dCas9-SunTagx10 was tagged with yellow fluorescent protein (YFP) rather than GFP.  
Genotyping of whole transformed plants was conducted by amplification of sections of the constructs 
from whole genomic DNA extracted from young plants. Primers specific to an 
adenosine diphosphate-ribosylation factor (ARF) gene (Kobayashi-Uehara et al., 2001) were used as a 
positive control. Genotyping was carried out on nine B3598 plants that germinated from 12 seeds 
planted. It was established that two plants were positive for both constructs; from this limited number 
of individuals, it appeared as though the constructs were co-segregating at this generation 
(Figure 3.3). The two positive B3598 plants (B3598.6 and B3598.9) and a negative plant (B3598.1) were 
carried forward for further study. Seed was collected from B3598.1, B3598.6 and B3598.9, and the 
thousand-grain weight was calculated to be 40.99 g, 31.87 g, and 31.49 g respectively. T3 progeny of 
B3598.6 and B3598.9, as well as T3 individuals of the E3 line, were also genotyped and 48.72% were 
positive for the SunTag constructs (n=39). This process established that the constructs necessary for 
the SunTag system had been successfully integrated into the genome.  
The number of genotyped plants that proved positive was lower than expected based on Mendelian 
ratios (Mendel, 1865); only 43.75% contained both SunTag constructs (n = 48), which appeared from 
the relatively small sample size to be co-segregating. The laws of Mendelian genetics would predict 
that 75% the progeny of a hemizygous parent to contain co-segregating constructs (Mendel, 1865). 
There are several possible reasons for this unexpected observation. The presence of the SunTag 
constructs may decrease fitness, so skewing the genotype of the seeds towards null individuals. Few 
studies have been conducted on the fitness costs of biolistic transformation, and those that have been 
carried out are based upon herbicide- or antibiotic-resistant transgenic plants (Guadagnuolo et al., 
2006; Purrington & Bergelson, 1997). The evidence presented in these studies is somewhat conflicting, 
with a fitness cost being incurred for some transgenes and not others (Purrington & Bergelson, 1997; 
Guadagnuolo et al., 2006). Across five measures of fitness and fecundity, no statistically significant 
differences were observed between transgenic and non-transgenic progeny of a selfed maize plant 
hemizygous for glyphosate resistance (Guadagnuolo et al., 2006). Purrington & Bergelson (1997) 





resistance gene, but not in those containing an antibiotic resistance gene or an empty plasmid. This 
suggests that the presence of a transgene itself is not detrimental due to resources being directed 
away from host growth and metabolism, commonly known as ‘metabolic drain’ (Glick, 1995). The 
antibiotic resistance plasmid found to not impart a fitness cost was 0.00872% of the size of the 
A. thaliana genome; the SunTag constructs inserted into the stably transformed wheat plants are, 
combined, just 0.000102% of the wheat genome. Theoretically, therefore, the SunTag constructs are 
too small to place a metabolic burden on the plants. 
The dCas9-SunTagx10 or VP64-ScFv proteins may interact with an endogenous gene in a deleterious 
manner, such as through competitive inhibition. This is not an unlikely scenario, as the constructs 
contain some common epitopes as well as motifs that are also present in the wheat genome, such as 
the H2B nuclear localisation signal. Therefore, any interactions that involve endogenous copies of H2B 
Figure 3.3: Gel electrophoresis (1% w/v agarose gel, 100 V, 2 h) of B3598 PCR products. The 
two primer sets used were dCas9 (Ub F & dCas9 R) and VP64 (Ub F & VP64-ScFv R). A 






















































































































































































































































































































































could feasibly also occur with the copy on the dCas9-SunTagx10 protein. To investigate this further, a 
deeper analysis of the other proteins pulled out by the co-IP experiments described in section 3.4 
could be conducted to elucidate any possible unforeseen interactions. A further co-IP and LC-MS 
analysis of its products should be conducted using antibodies specific to the VP64-ScFv protein to 
discover any possible detrimental interactions between VP64-ScFv and endogenous proteins. This 
result, alongside the low transformation rate observed in protoplasts, suggests one or both SunTag 
constructs may be deleterious in wheat. In all protoplasting trials, some protoplasts were observed to 
have died. Whether these were transformed or wild type (WT) cells could not be determined as any 
GFP could have degraded, and cell death causes autofluorescence (Grønlund et al., 2012). Therefore, 
it is unknown whether transformed cells had a higher death rate than WT protoplasts. However, it is 
possible to sort protoplasts using fluorescence-activated cell sorting (FACS), which has previously been 
used to separate transformed, non-transformed, and dead or dying A. thaliana protoplasts 
(Grønlund et al., 2012). The percentage of each type of cell transformed could then be qualitatively 
estimated via PCR to determine whether there is a substantial difference between the transformation 
rate in protoplasts that have and have not survived, although this method would not be likely to detect 
more subtle differences in transformation rates.  
The lower thousand seed weight for plants containing the SunTag constructs is additional evidence for 
the constructs being detrimental to plant fitness. However, the sample sizes were not large enough to 
determine statistical significance. Further work, such as the FACS study described previously, is 
needed to clarify whether the constructs are deleterious or not.  
A low transformation rate would not pose a serious issue during stable transformation, as the 
constructs only need to be incorporated into the genome once to eventually create a stably expressing 
non-segregating line. This issue may, however, necessitate the bombardment of a larger number of 
calli to successfully obtain transformants.  
3.2 TRANSCRIPTION 
The presence of dCas9-SunTagx10 and VP64-ScFv mRNA, both in vitro and in planta, was verified by 
RT-PCR conducted on total RNA extracted from both protoplasts and plants B3598.6 and B3598.9 
(Figures 3.4 and 3.5). The sizes of the bands correspond to those of correctly spliced mRNA. The sizes 
of the cDNA fragments are smaller than those of the full DNA sequences because the ubi1 promoter 
intron is spliced out during mRNA maturation. Therefore, the smaller fragment sizes observed in 






It also suggests that there was no DNA contamination, which would be expected to consist of the 
larger, unspliced fragments. To explicitly show that these products were amplified from SunTag 
construct RNA, the cDNA was sequenced and aligned to the expected sequence. All products 
sequenced were as expected, including correct splicing of the ubi1 promoter intron.  
The smearing in Figure 3.5 might indicate an issue with the RT-PCR. One explanation may be incorrect 
loading. The quantity of RNA used as a template for the RT-PCRs was 500ng, within the range 
recommended by the RT-PCR reaction mix manufacturer. The concentration of each RNA sample, and 
therefore the volume of each sample to be added to each reaction, was quantified using a Nanodrop 
spectrophotometer. This method does not distinguish between RNA and DNA, however, as the RNA 
samples were DNase treated it is unlikely there was any DNA contamination which would make the 
concentration readings unreliable. The number of cycles used may have been too high, producing a 
higher than expected concentration of product. However, in preliminary studies, a lower number of 
cycles did not produce any visible bands during gel electrophoresis. It is unlikely to be the result of 
DNA crossover or contamination as the negative control lanes are free from any signal. It may be due 
to a non-optimal magnesium ion concentration, which can lead to a high level of background. This is 
somewhat unlikely, as the reaction buffer was used according to the manufacturer's 
Figure 3.4: Gel electrophoresis (2% w/v agarose gel, 100 v, 2 h 30 min) of protoplast RT-PCR 
products. There were five sets of protoplasts to which different transformation treatments 
were applied: 1) negative control; 2) GFP reporter plasmid; 3) dCas9-SunTagx10 plasmid: 4) 
VP64-ScFv plasmid; 5) co-transformation with the dCas9-SunTagx10 and VP64-ScFv plasmids. 
The four primer sets used were ARF (ARF (F) & ARF (R)), GFP (Ub (F) & H2B (R)), dCas9 (Ub (F) 
& dCas9 (R)), and VP64 (Ub (F) and VP64-ScFv (R)). A New England Biolabs Inc. 































































































































































































































instructions, which eliminates the need for magnesium ion concentration optimisation. However, this 
could be an unusual case where a more ‘extreme’ magnesium ion concentration is necessary. 
0.015 µM of each primer was used, which is far lower than the 0.6 µM which QIAGEN recommends. 
This decision was based on previous studies carried out within the Edwards’ group; however, a higher 
concentration could be trialled. 
Despite these possible issues, the fact that the smears are not seen in negative controls but are also 
seen in positive controls suggests this is an issue with procedure rather than the starting material. In 
future, given more time, further optimisation of the protocol should be carried out. 
3.3 TRANSLATION 
To ensure that construct mRNA was subsequently being translated into dCas9-SunTagx10 and 
VP64-ScFv proteins, Western blots were carried out on total protein extracted from stably 
transformed plants. The antibody used was ‘Cas9 antibody 3’, the details of which are given in 
Figure 3.5: Gel electrophoresis (2% w/v agarose gel, 80 v, 4 h) of B3598 RT-PCR products. 
The three primer sets used were ARF (ARF (F) & ARF (R)), dCas9 (Ub (F) & dCas9 (R)), and 
VP64 (Ub (F) and VP64-ScFv (R)). A New England Biolabs Inc. (Waltham, MA, USA) 






























































































































































































Table A.1. Two other antibodies were also produced at the same time against two different peptides, 
however, in trials carried out by Professor Keith Edwards (University of Bristol; Bristol, UK) these were 
found to be less sensitive and less specific than antibody 3 (personal communication). A commercial 
Cas9 nuclease was used as a positive control in the form of serial dilutions in all blots, however, in 
trials, it was noted that this did not appear to be running at the expected 159 kDa size for the protein 
(Figure 3.6). To see whether this was as a result of the protein being degraded (as it was running 
smaller than expected) or the size standards not running at the expected size, a different Cas9 
nuclease (synthesised by Dr Lucy Hyde (University of Bristol; Bristol, UK)) was run on the same blot as 
Figure 3.6: Western blot of New England Biolabs Inc. (Waltham, MA, USA) Cas9 nuclease. The 
mass of Cas9 nuclease stated for each lane is suspended in WT wheat cv. Cadenza total protein 


































































































a serial dilution (Figure 3.7). In this trial, both Cas9 proteins migrated the same distance on the gel, 
which corresponded to the incorrect size according to the SeeBlue™ Plus 2 pre-stained protein 
standards. Therefore, it was concluded that the size standard could not be relied upon for protein size 
determination. It was, however, still included in Western blot experiments as an indication of how far 
the gel had run, and therefore for how long the voltage should be applied.  
No signal was detected for total protein extracted from plant B3598.6 (Figure 3.8). This suggests that 
either the level of SunTag construct expression is low, or the proteins are not being expressed at all. 
However, there is also the possibility that the protein was not being extracted using the Sigma-Aldrich
 
Figure 3.7: Western blot of New England Biolabs Inc. (Waltham, MA, USA) Cas9 nuclease and 




















































































































protein extraction kit (as described in section 2.5.1). This may be due to the dCas9-SunTagx10 protein 
not being soluble in the lysis buffer. Therefore, two other techniques were tested (as described in 
sections 2.5.2 and 2.5.6), however, a negative result was also obtained for these samples. The 
sensitivity achieved for these Western blots was around 2ng of protein per sample. Therefore other, 
more sensitive techniques were necessary to detect any possible low level of construct expression.  
Samples were sent to Dr Kate Heesom at the University of Bristol proteomics facility for liquid 
chromatography-mass spectrometry (LC-MS) analysis. Cell lysate extracted from plants B3598.6 and 
B3598.9 was used in the initial study. No peptides matching the VP64-ScFv protein were detected. The 
Figure 3.8: Western blot of B3598.1, 6 and 9 total protein. New England Biolabs Inc. 
(Waltham, MA, USA) Cas9 nuclease is a positive control. The mass of Cas9 nuclease stated for 
each lane is suspended in WT wheat cv. Cadenza total protein extract. Primary antibody: 



























































































only peptides detected which matched the dCas9-SunTagx10 protein amino acid sequence were part 
of the H2B sequence included in the construct as a nuclear localisation signal. The peptides detected 
are also present in the endogenous copy of H2B in wheat, and therefore the source of these peptides 
could not be determined. It was concluded that the peptides were unlikely to be from the 
dCas9-SunTagx10 protein due to the absence of other peptides from other, unique regions of the 
construct. Therefore, the most likely explanations are that either the SunTag constructs were not 
present, or were being expressed at a level too low to be detected by LC-MS.  
3.4 PROTEIN INTERACTION 
To both enrich the protein sample for LC-MS analysis and to determine whether the VP64-ScFv and 
dCas9-SunTagx10 proteins interact in planta, a co-immunoprecipitation (co-IP) reaction was conducted 
on a leaf sample from plant B3598.6. The coupling efficiency of the antibodies to the agarose beads 
for all three positive reactions was over 63%. The co-IP products were run on a gel and blotted using 
Cas9 antibody 3 (Figure 3.9). Again, no definitive signal was detected. Some bands were visible for the 
three positive co-IP reactions which were not present for the negative control reactions. This suggests 
that these proteins bound to all three Cas9 antibodies and so the detected protein has some sequence 
homology to the Cas9 nuclease. There is the possibility that it is the dCas9-SunTagx10 protein although 
its position on the gel indicates that it was a great deal smaller than the Cas9 control protein which is 
159 kDa. The expected size of the dCas9-SunTagx10 protein is 198.16 kDa, so the signal observed in 
Figure 3.9 is highly unlikely to be the full dCas9-SunTagx10 protein. The smallest dCas9-SunTagx10 
protein fragment which contains all three antibody epitopes is 126.88 kDa, so the signal may have 
been a degraded form of the dCas9-SunTagx10 protein. The signal is unlikely to be the 72.81 kDa 
VP64-ScFv protein as the primary antibody used for the Western blot was specific to Cas9. Finally, the 
smaller-than-expected signal could be the result of non-specific antibody binding, although this is 
unlikely as the signal was not present in the negative controls.  
As a result of this uncertainty, the samples were sent for LC-MS analysis, the results of which are 
shown in Table 3.1. Peptides uniquely matching the VP64-ScFv protein amino acid sequence were 
detected in all three co-IP products, and were not present in either negative control (co-IPs 4 and 5). 
However, once again the only peptides detected relating to the dCas9-SunTagx10 construct were within 





Although the presence of the dCas9-SunTagx10 protein was never shown, through either Western blots 
or LC-MS, the results of the co-IP LC-MS run strongly suggest it is present but at levels too low to be 
detected. It also indicated that the two SunTag proteins are binding to each other. This is because the 
antibodies bound to the agarose beads should pull out the dCas9-SunTagx10 construct and any proteins 
bound to it; the presence of VP64-ScFv peptides is dependent on the presence of the dCas9-SunTagx10 
protein which it theoretically binds to. There are, however, alternative possible explanations for this 
result. The VP64-ScFv protein may be non-specifically binding to the Cas9 antibody directly. This is 
Figure 3.9: Western blot of co-immunoprecipitation products. New England Biolabs Inc. 
(Waltham, MA, USA) Cas9 nuclease is a positive control. Co-IP samples 1, 2, and 3 were 
carried out using Cas9 antibodies 1, 2, and 3 respectively bound to agarose beads. Co-IP 4 


















































































unlikely as the amino acid sequences of the peptides the three Cas9 antibodies were raised against 
are not present in the VP64-ScFv amino acid sequence. It would additionally have to bind non-
specifically to all three antibodies (as it was detected in all three co-IP reaction products). The protein 
may bind to the agarose beads, however, this is also unlikely as the cell lysate was pre-cleared, 
meaning any proteins that bound to the bead should have been discarded at this stage and should not 
be present in the final product.  
A total of 264 peptides were detected by the LC-MS run that were pulled out by all three Cas9 
antibodies, but not by the control treatments. This suggests the specificity of the co-IP experiment 
could be improved, possibly by using different antibodies or by increasing the number of wash steps. 
However, this would also be likely to decrease the yield of any target protein. This may explain the 
presence of the signal in the Western blot of the co-IP products (Figure 3.9); these may be 
non-specifically binding products. Additionally, the lower molecular weight bands in Figure 3.9 appear 
to be in a similar position to the background observed in Figure 3.6 for WT protein extractions.  
The possibility of the dCas9-SunTagx10 protein being unstable, a hypothesis raised in section 3.1.2, is 
unlikely considering the co-IP LC-MS results. The dCas9-SunTagx10 protein would have to be present 
and intact for long enough for it to bind to the agarose beads along with the VP64-ScFv, remain bound 
during washing steps and subsequently be eluted.  
Table 3.1: LC-MS analysis of co-IP products detailing the peptide hits aligning uniquely to the 
proteins of interest (VP64-ScFv and dCas9-SunTagx10). ‘Coverage’ indicates the percentage 
of the protein sequence covered by the peptides detected. ‘Peptides’ indicates the number 
of different peptides detected that match the protein of interest. ‘Unique peptides’ indicates 
the number of peptides detected that are unique to the protein of interest. ‘Area’ is an 
indication of protein abundance, which is calculated as the average area under the three 








Co-IP 1 VP64-ScFv 7.42 3 3 2183724.938 
Co-IP 2 VP64-ScFv 5.09 3 3 4092338.219 
Co-IP 3 VP64-ScFv 9.34 3 3 3453820.135 
Co-IP 4 No hits 






The above strongly suggests that the dCas9-SunTagx10 protein is present in transgenic tissue along with 
the detected VP64-ScFv protein and that the two proteins are interacting; the project was continued 
under this assumption. Subsequent experiments attempting to put the SunTag system into practice 
would, in any case, establish whether these essential elements of the system were present.  
3.5 CONCLUSION 
In this chapter the first and second aims of this study, as set out in section 1.7, have been mostly 
satisfied: to “Implement transient and stable expression of a modified SunTag system in wheat cells 
and plants” and “Verify that the dCas9-SunTagx10 and VP64-ScFv SunTag constructs are present in 
wheat cells and plants, and are expressing the corresponding mRNA and proteins. Verify that these 
SunTag proteins are interacting”.  
The successful transformation of both protoplasts (in vitro) and plants (in planta) with the two novel 
SunTag constructs was shown through the observation of GFP tags, as well as PCRs. The presence of 
correctly spliced mRNA for both constructs was demonstrated through RT-PCR studies. Finally, 
evidence for the presence of the VP64-ScFv protein was obtained through co-IP and LC-MS, while the 
presence of the dCas9-SunTagx10 protein was strongly suggested by the presence of the VP64-ScFv 
protein. An interaction between the two SunTag products was also indicated by the co-IP LC-MS result.  
Although not conclusive, the evidence described above was determined to be strong enough to 
continue the study and put the SunTag system into practice to attempt to satisfy the third aim of the 
project, to “Induce specific gene expression of both inserted and endogenous genes, and quantify any 
changes in gene expression”. A positive result from the RNA-seq experiment described in Chapter 4 







CHAPTER 4: IMPLEMENTATION OF THE SUNTAG SYSTEM IN WHEAT 
PROTOPLASTS 
To assess whether the SunTag system can induce specific gene expression in wheat, it was used to 
target the promoter regions of two genes and comparative gene expression analysis was conducted 
using RNA-seq. The first gene targeted was the exogenous maize ubi1 promoter, which drives 
expression of the SunTag constructs (Figure 2.1). In theory, if the system were to successfully increase 
the activity of the ubi1 promoter, a positive feedback loop would be created and the SunTag constructs 
would upregulate themselves. The ubi1 promoter has a high, constitutive base level of expression 
(Christensen et al., 1992). The second target for the SunTag system was the endogenous 
Photoperiod-D1 (Ppd-D1) gene. Ppd-D1 is a well-characterised gene located on the D-genome which 
controls photoperiod sensitivity in wheat (Guo, 2010). Cadenza, the wheat variety used throughout 
this study, contains a photoperiod sensitive allele of Ppd-D1 (Farré et al., 2016) which has a low base 
level of expression of approximately 4.72 transcripts per million (TPM) (Ramírez-González et al., 2018).  
The aim of this chapter was to assess the effect on gene expression of the SunTag system with sgRNA 
pools targeted to the ubi1 and Ppd-D1 promoter regions in wheat protoplasts. The effect on the 
expression of both the target genes and the rest of the transcriptome was evaluated using RNA-seq, 
to assess the system’s efficiency and off-target effects.  
4.1 QUALITY CONTROL OF RNA-SEQ DATA 
An RNA-seq run was conducted as described in section 2.6. In brief, total RNA was isolated from wheat 
protoplasts generated from WT and B3598.6 plants (the latter segregates for both SunTag constructs). 
Protoplasts were additionally transformed with sgRNAs targeting the ubi1 or Ppd-D1 promoter as 
detailed in Table 2.1.  
The quality of the RNA-seq reads was assessed using FASTQC (Andrews, 2018). The mean quality 
scores at all read positions had Phred scores greater than 28 and were, therefore, determined to be 
‘good’, with a small decrease in quality at the end of the read (Figure 4.1). This degradation of quality 
scores is expected and is often the result of phasing (or pre-phasing) during sequencing by synthesis, 
where reads become ‘out-of-step’ with one another (ecSeq Bioinformatics, 2017). This is frequently 
due to errors in removing terminator caps during sequencing cycles, meaning a single nucleotide may 
be read twice, or a nucleotide is skipped. This issue is widely described (ecSeq Bioinformatics, 2017), 







The overall quality score of each sequence was also analysed (Figure 4.2). Most of the reads had a 
‘good’ mean quality score. This analysis, along with the data presented in Figure 4.1, provides evidence 
that all the samples had a similar, good quality profile.  
The GC content of the reads was analysed using FastQC and all samples failed the FastQC GC content 
module (Figure 4.3). The samples showed a positively skewed distribution, as opposed to the expected 
normal distribution. Also, several small peaks were observed, including one only seen in reverse reads 
(indicated in Figure 4.3 by an arrow). Additional peaks are often an indication of contamination, such 
as adapter dimers. The peak at 48% matches the estimated GC content for wheat cDNA assemblies of 
47.74% (Brenchley et al., 2012). Although the samples failed this FastQC module, this was determined 
to be acceptable. The sequencing libraries passed all quality control checks (data not shown), so there 
was unlikely to be any contamination at the library preparation stage. However, there is the possibility 
of that contamination occurred subsequently during the sequencing workflow. Also, RNA-seq studies 
can produce skewed GC-content distributions due to the presence of naturally occurring 
overrepresented sequences. FastQC assumes the sequencing libraries are random, which RNA-seq 
libraries will not be.  
Figure 4.1: The mean quality scores of all raw RNA-seq reads at each read position. Each line 
represents the forward or reverse reads for a single sample. Green shading represents ‘good’ 
Phred scores (>28), orange shading represents ‘reasonable’ scores (20-28) and red represents 





Figure 4.3: The percentage of reads per sample with each average GC content value. Lines 
represent either the forward or reverse reads for a single sample. The arrow indicates a peak 
which is present in the graphs generated for reverse reads and absent in forward reads. Figure 
produced using FASTQC (Andrews, 2018). 
Figure 4.2: The number of raw RNA-seq reads with each mean sequence quality score. Each line 
represents the forward or reverse reads for a single sample. Green shading represents ‘good’ 
Phred scores (>28), orange shading represents ‘reasonable’ scores (20-28) and red represents 





Attempts to improve the quality of the reads were made by trimming them according to a database 
of Illumina adapters (provided by Dr Alex Paterson (University of Bristol Genomics Facility; 
Bristol, UK)). The trimmed reads were again assessed using FastQC, and no substantial improvements 
were made on the quality of the reads for any FastQC module. Therefore, the raw reads were used to 
avoid inadvertently losing any potentially informative data.  
4.2 RNA-SEQ RESULTS 
4.2.1 ubi1 Experiment 
Based on the results of the DeSeq2 analysis (as described in section 2.6.4) (Love et al., 2014), there 
was a statistically significant increase in the expression of both SunTag constructs VP64-ScFv (1.89-fold 
increase, p < 0.001, Figure 4.4) and dCas9-SunTagx10 (1.65-fold increase, p = 0.012, Figure 4.5) in 
B3598.6 protoplasts transformed with ubi1 sgRNAs compared to non-transformed B3598.6 
protoplasts. There was no statistically significant change in the expression of dCas9-SunTagx10 or 
VP64-ScFv in B3598.6 protoplasts when transformed with Ppd-D1 sgRNAs. There was a statistically 
significant difference in the expression of VP64-ScFv in B3598.6 protoplasts transformed with ubi1 
sgRNAs compared to Ppd-D1 sgRNAs (1.65-fold change, p = 0.017). However, there was no statistically 

























Figure 4.4: Normalised expression levels of VP64-ScFv in protoplasts generated from WT wheat 
and line B3598.6 which contains the SunTag constructs. Normalised expression level data was 
generated by DeSeq2 as described in section 2.6.4 (Love et al., 2014). Protoplasts were 
transformed with sgRNAs targeting the ubi1 promoter or the Ppd-D1 promoter. Error bars 





ubi1 sgRNAs compared to Ppd-D1 sgRNAs (p = 0.874). The expression data for VP64-ScFv suggests that 
the CRISPRa system can be used to increase gene expression and is specific according to the sgRNAs 
used. The expression data for dCas9-SunTagx10 are inconclusive.  
4.2.2 Ppd-D1 Experiment 
No statistically significant difference in Ppd-D1 expression was detected in cells transformed with 
Ppd-D1 sgRNAs. The normalised expression level of Ppd-D1 in cells containing the SunTag constructs 
and sgRNAs targeting Ppd-D1 indicated that there were no Ppd-D1 transcripts present (Figure 4.6). 
The adjusted p-value for Ppd-D1 was excluded from the results of the DeSeq2 analysis as a result of 
independent filtering. Independent filtering aims to increase the power of the statistical analysis by 
ensuring all adjusted p-values satisfy a false discovery rate threshold. This is achieved by excluding 
genes with very low levels of expression. The expression level of Ppd-D1 was determined by DeSeq2 

























Figure 4.5: Normalised expression levels of dCas9-SunTagx10 in protoplasts generated from WT 
wheat and line B3598.6 which contains the SunTag constructs. Normalised expression level data 
was generated by DeSeq2 as described in section 2.6.4 (Love et al., 2014). Protoplasts were 
transformed with sgRNAs targeting the ubi1 promoter or the Ppd-D1 promoter. Error bars 






4.2.3 SunTag System Specificity 
It is important to estimate any off-target effects of the SunTag system if it were to become a useful 
tool, as it would need to be both powerful and specific. The principal component analyses in 
Figures 4.7 and 4.8 show the global effect on the transcriptome of transforming cells with the two 
SunTag constructs and sgRNAs. In both studies the groups expressing the SunTag constructs cluster 
together. 2733 genes were differentially expressed in cells containing SunTag compared to WT cells. 


























Figure 4.6: Normalised expression levels of Ppd-D1 in protoplasts generated from WT wheat 
and line B3598.6 which contains the SunTag constructs. Normalised expression level data was 
generated by DeSeq2 as described in section 2.6.4 (Love et al., 2014). Protoplasts were 
transformed with sgRNAs targeting the ubi1 promoter or the Ppd-D1 promoter. Error bars 





15,042 genes were differentially expressed in B3598.6 cells containing the SunTag constructs and ubi1 
sgRNAs compared to WT cells. A BLAST (Basic Local Alignment Search Tool) search conducted by 
Dr Gary Barker (University of Bristol; Bristol, UK) showed that only 7 of these genes shared sequence 
similarity (maximum of one mismatch) with the ubi1 sgRNAs, none of which were within the optimum 
range for CRISPRa sgRNA design. Compared to WT cells 3,881 genes were differentially expressed in 
Figure 4.7: Principle component analysis (PCA) of RNA-seq data from WT and B3598.6 
protoplasts transformed with sgRNA constructs targeting the ubi1 promoter. The ‘group’ 
indicates the treatments applied to each sample. There were two replicates per treatment. The 
percentages assigned to each axis refer to the percentage of the data described by that principle 
component. Figure produced using DeSeq2 (Love et al., 2014).  
Figure 4.8: Principle component analysis (PCA) of RNA-seq data from WT and B3598.6 
protoplasts transformed with sgRNA constructs targeting the Ppd-D1 promoter. The ‘group’ 
indicates the treatments applied to each sample. There were two replicates per treatment. The 
percentages assigned to each axis refer to the percentage of the data described by that principle 





cells containing the SunTag constructs and Ppd-D1 sgRNAs. Of these differentially expressed genes, 22 
shared some sequence similarity (maximum of one mismatch) with the Ppd-D1 sgRNAs. Only one of 
these matching motifs was in the optimum range for the CRISPRa system. The differentially expressed 
genes were located on all chromosomes in all genomes and had a range of basal expression levels.  
4.3 INTERPRETATION OF THE RESULTS 
This study was unable to replicate the results of at least a 10-fold increase in gene expression reported 
by Tanenbaum et al. (2014) in human cells. This may suggest that the SunTag system is not as powerful 
when used in wheat, however, the lack of any observed gene upregulation may be the result of 
mistargeted sgRNAs. Gilbert et al. (2014) suggested that designing sgRNAs to target -400 to -50 bp 
from the transcription start site induces the greatest average level of upregulation for the SunTag 
system. The ubi1 sgRNAs were designed to target the optimal range at 
positions -121 bp, -148 bp, -235 bp, and -258 bp (Figure 2.2, Table A.2), while the Ppd-D1 sgRNAs were 
targeted to sequences between the transcription start site and the translation start site ranging from 
positions +68 bp to +552 bp (Figure 2.2, Table A.2). Therefore, the TADs of the SunTag system were 
not targeted to the optimum range. This could be an alternative reason that transformation of B3598.6 
with Ppd-D1 sgRNAs resulted in no change in Ppd-D1 gene expression. The SunTag complex may have 
physically interfered with transcription, inhibiting mRNA production. Further work could be 
undertaken with sgRNAs designed according to the suggestions made by Gilbert et al. (2014), or 
ideally, a separate preliminary study should be undertaken to determine the optimal sgRNA target 
range in wheat.  Also, Ramírez-González et al. (2018) reported that the base level of expression of 
Ppd-D1 is very low at just 4.72 TPM. This means that any small increase in gene expression would have 
been difficult to detect. In future work, a higher number of replicates or a more sensitive technique 
could be used, for instance, qRT-PCR (quantitative RT-PCR). However, this technique could not be used 
to assess off-target effects, as it is used to quantify the expression of a single gene.  
The results of the PCA suggest that the insertion of SunTag constructs affects gene expression globally, 
even in the absence of sgRNAs. Almost none of the differentially expressed genes showed any 
sequence similarity to the sgRNAs used, so the change in expression was unlikely to have been due to 
imperfect binding between the sgRNAs and endogenous DNA. This high number of differentially 
expressed genes was not observed by other studies using the SunTag CRISPRa system 
(Konermann et al., 2015), or studies using dCas9 to repress genes (Gilbert et al., 2013a). This is a 
surprising result which should be investigated further, as all the treated cells showed unexpected 
differential expression patterns compared to the WT. However, some of the differentially expressed 





that any stochasticity in gene expression would have had a large impact on the analysis. Therefore, 
further studies with more replicates should be carried out.  
4.4 LIMITATIONS OF THE RNA-SEQ ANALYSIS  
The number of replicates in this study was two per treatment, however, Schurch et al. (2016) 
suggested that three replicates are the minimum required for RNA-seq and that 12 is ideal. This was 
supported by the high standard errors of the mean for the data points in Figures 4.4, 4.5 and 4.6; these 
reflect the natural variation in gene expression which may have obscured patterns caused by the 
treatments applied. Therefore, the number of replicates in this study was not sufficient to determine 
conclusively whether there was upregulation of Ppd-D1 expression in B3598.6 protoplasts treated 
with Ppd-D1 sgRNAs. Further RNAseq studies should include a greater number of replicates to assess 
the viability of this CRISPRa system.  
The tissue used to generate the protoplasts came from heterogeneous seed stock due to the 
unavailability of a homozygous line. Therefore, not all cells within the B3598.6 protoplast pool 
contained the SunTag constructs, so the CRISPRa system would have only worked in a proportion of 
the cells in the sample (43.75% according to the genotyping described in section 3.1.3). A 
non-segregating seed stock should be generated to fairly assess the effectiveness of this system in 
wheat. Additionally, not all cells would have been transformed with the sgRNAs. Therefore, any small 
increase in gene expression in transformed cells may be undetectable. Furthermore, any detected 
increases in expression are likely to be underestimates of the potential of the system. A temporary 
solution to this issue would be fluorescence activated cell sorting (FACS) of the protoplasts, as 
transformant cells are tagged with sfGFP and YFP. 
Future work would allow the SunTag system to be assessed more comprehensively. It has been noted 
in previous studies that there can be a large amount of variation in the level of upregulation of gene 
expression achieved, even when targeting the same gene (Maeder et al., 2013). It has been proposed 
that this is the result of competitive binding of endogenous transcription factors, variation in the level 
of binding the SunTag complex achieves with the DNA (Maeder et al., 2013), the endogenous 
epigenetic state of the target DNA, or the base level of gene expression (Chavez et al., 2015). These 
effects could be controlled in multiple ways. For instance, targeting a single endogenous gene is not 
ideal, as there may be a specific reason why the system would be less effective when targeted to it. 
For instance, Ppd-D1 is partially regulated by the circadian clock (Kiseleva et al., 2017; 
Boden et al., 2015), meaning the expression level would be affected by the time at which the RNA was 
extracted. Ideally, a range of genes should be targeted with different endogenous expression patterns 





excellent candidates for assessing the off-target effects of the system, as increases in the expression 
of downstream genes can be confused with non-specific upregulation. Additionally, genes with low, 
medium, and high base levels of expression should be targeted to assess the effect of endogenous 
gene expression on the level of upregulation. It must also be considered that some genes may be 
components of regulatory loops, meaning that their expression is limited by other genes. Therefore, 
the level of possible upregulation of a target gene may be limited without altering the expression of 
other genes in the network.  
Given these factors which can affect the level of upregulation possible, it is also important to account 
for differences in the effectiveness of the system in different tissues of wheat plants, or at different 
developmental stages. The promoters driving the expression of SunTag constructs may not act 
constitutively in all tissues at all times (Chapter 3.1.2), and the same may be the case for the promoter 
driving the sgRNA constructs. Therefore, ideally, RNA should be sampled from various tissues at 
various stages of development to assess the effectiveness of the CRISPRa system in the entire plant, 
not only in protoplasts generated from young leaf tissue.  
A further extension of this work would be to assess the phenotypic effect induced upregulation has 
on the plants. This has been used to assess the effectiveness of SunTag in A. thaliana where the system 
was used for targeted DNA methylation (Papikian et al., 2019). This would most likely require plants 
stably transformed with both the SunTag constructs and sgRNAs to measure any change in phenotype.  
4.5 CONCLUSIONS 
This study showed that the SunTag CRISPRa system may increase expression of exogenous genes 
which form part of a feedback loop in wheat protoplasts by a mean of 1.77-fold. However, no increase 
in gene expression was observed when the SunTag system was targeted to endogenous gene Ppd-D1. 
These results suggest that although the SunTag system is functional, it is not capable of high levels of 
gene upregulation in wheat protoplasts. Further work would determine whether the system can be 





CHAPTER 5: DISCUSSION  
5.1 SUMMARY OF FINDINGS 
5.1.1 Aim 1: Implement transient and stable expression of a modified SunTag system in wheat 
cells and plants 
Transformation of protoplasts and plants with the two SunTag constructs, dCas9-SunTagx10 and 
VP64-ScFv, was achieved. Transient expression in protoplasts was confirmed using fluorescent 
microscopy to observe GFP tags. Stable transformation in planta was confirmed using PCR. The 
transformation rate was lower than predicted for both transient and stable transformation. The 
hypotheses to explain the low transformation rate include weak construct expression, and the 
constructs having deleterious effects in wheat.  
5.1.2 Aim 2: Verify that the dCas9-SunTagx10 and VP64-ScFv SunTag constructs are present in 
wheat cells and plants, and are expressing the corresponding mRNA and proteins. Verify that 
these SunTag proteins are interacting 
The presence of correctly processed mRNA was verified in protoplasts and stably transformed plants 
using RT-PCR. The presence of the VP64-ScFv protein was shown through LC-MS analysis of co-IP 
products. The presence of the dCas9-SunTagx10 protein was implied based upon the co-IP LC-MS 
results; the presence of the VP64-ScFv protein was reliant on the presence of dCas9-SunTagx10 protein. 
The SunTag proteins were also strongly suggested to have been interacting based on the co-IP LC-MS 
study. 
5.1.3 Aim 3: Induce specific gene expression of both inserted and endogenous genes, and 
quantify any changes in gene expression 
The system was shown to significantly upregulate the ubi1 promoter with a mean 1.77-fold increase 
in SunTag construct expression. When sgRNAs targeting Ppd-D1 were used, no increase in Ppd-D1 
expression was detected.  
The ubi1 study involved a positive feedback loop, which was likely to increase the level of upregulation 
achieved. Therefore, one hypothesis to explain this result is that the level of upregulation possible 
without this positive feedback loop is too low to be detected. The base level of Ppd-D1 expression was 
low, making any increase in expression more difficult to identify. Further optimisation of the CRISPRa 





5.2 LIMITATIONS OF THE STUDY 
Although all the objectives of this study were fulfilled, there were some issues which require further 
investigation.  
The evidence of the presence of the dCas9-SunTagx10 protein, as well as its interaction with the 
VP64-ScFv protein, was based on assumptions made about the co-IP LC-MS analysis. This falls short of 
conclusive evidence, however, the RNA-seq data strongly suggests that both these proteins are 
present and interacting as the CRISPRa system should not work unless this is the case. Further work 
could be completed to provide stronger evidence; for instance, by optimising the co-IP reaction to 
reduce the number of non-specific proteins in the final sample; this would improve the likelihood of 
detecting the dCas9-SunTagx10 protein.  
One of the main limitations of the RNA-seq study was the lack of replicates; there were only two per 
treatment. There was considerable stochasticity between replicates. This reduces the power of any 
statistical analysis carried out on the data and so smaller changes in expression may not be detected.  
The other main limitation was that not all cells within a sample had the same genotype. At the time 
of the study setup, no non-segregating line transformed with the SunTag constructs had been 
generated. Therefore, the shoots from which the protoplasts were isolated would have been a mix of 
positive and negative genotypes. Also, the sgRNA plasmids would not have transformed 100% of cells. 
This makes it difficult to estimate the level of upregulation possible using the CRISPRa system and 
means that more subtle effects may have been undetectable.  
5.3 FURTHER WORK 
5.3.1 Optimising the System 
It is important to note that the system was only implemented in vitro, and so the next logical step 
would be to apply it in planta. The SunTag constructs have been shown to express in stably 
transformed plants (section 3.2.3). sgRNAs would also need to be either transiently or stably 
expressed in these plants. If stable expression were required, the sgRNA constructs would need to be 
inserted into the genome using Agrobacterium tumefaciens-mediated or biolistic techniques. 
However transient expression could also be induced very simply with a novel transformation 
technique using nanoparticles, as described by Doyle et al. (2019).  Implementing the system in planta 
would allow a more accurate estimation of the power of this CRISPRa system, as all cells should contain 
the SunTag constructs. All cells would contain sgRNAs if plants were stably transformed with the 
sgRNA constructs. This may mean that any small increase in gene expression induced by the SunTag 





There is enormous potential for development beyond the studies described here. Initially, the system 
needs to be optimised for use in wheat, as at present it is not capable of upregulating at least some 
endogenous genes. The length of the amino acid linkers between GCN4 epitopes has been shown to 
strongly affect the activity of the associated effector molecules (Morita et al., 2016). For instance, in 
a study by Morita et al. (2016) where gene activation was achieved using the DNA demethylator TET1 
(ten-eleven translocation methylcytosine dioxygenase 1), the standard SunTag system showed no 
improvement over a simple protein fusion. However, by optimising linker length, demethylation rates 
were increased from 14% to 38% (Morita et al., 2016). This optimisation strategy could be 
implemented to improve the CRISPRa system discussed here. Other variables should also be 
investigated and optimised, such as the number of GCN4 epitopes in the SunTag array. TADs other 
than VP64 could be used, such as VPR (Chavez et al., 2015) or TV (Li et al., 2017). A recent study tested 
different CRISPRa techniques in N. benthamiana; SunTag was found to not be the most effective 
CRISPRa system (Selma et al., 2019). scRNA-gRNA2.1 combined with dCas9:EDLL-MS2:VPR induced 
the greatest level of upregulation (Selma et al., 2019). A similar optimisation study could be conducted 
in wheat to ascertain which approach is most effective, as variation in transcriptional machinery and 
promoter structure in different species may affect which system is most powerful and specific. This 
work would help to increase the power of the system sufficiently to be capable of upregulating 
endogenous genes.  
It is also important to consider whether spCas9 is the most efficient Cas9 orthologue to use. As 
mentioned in section 1.1, comparative studies have shown that there may be more effective or 
specific variants than spCas9, even though it is the most used nuclease (Gilbert et al., 2013a). 
Orthologues of dCas9 from species other than S. pyogenes have been used for fluorescent labelling 
(Chen et al., 2016). In addition, Rock et al. (2017) screened multiple dCas9 orthologues for use in 
Mycobacterium tuberculosis to decrease gene expression. They found that the dCas9 orthologue from 
Streptococcus thermophilus (CRISPR1 variant) was over 20 times more efficient than the S. pyogenes 
orthologue (Rock et al., 2017). This shows the importance of choosing the correct orthologue for a 
target species. sgRNA design is also vital, as shown by Gilbert et al. (2014), who found that the optimal 
position for CRISPRa sgRNAs is -400 to -50 bp upstream of the transcription start site. A similar study 
could be conducted in wheat to ensure this optimal window is the same as Gilbert et al. (2014) 
observed in human cells, as the different transcriptional machinery in plants may alter this.  
Another factor to be investigated is the number of locations the system is used to target. SunTag has 
been successfully used to target multiple genes concurrently by multiplexing sgRNAs (Papikian et al., 
2019); this could be tested in wheat. The polyploid nature of wheat could be interrogated using this 





Ppd-D1 study described here, only the D-genome copy was targeted. In future, the effect of targeting 
additional gene copies on the A and B genome could be assessed. In some cases, certain copies of a 
gene are more influential on the phenotype than others, in which case targeting different 
combinations of homeologues would influence the level of upregulation observed. By using CRISPRa 
to upregulate each homeologue separately, the influence of each gene copy could also be 
investigated.  
5.3.2 Creating a More Flexible System 
There is scope for making the SunTag CRISPRa system more flexible, meaning that it could be applied 
to a greater number of research questions. The constructs could be driven by an inducible promoter 
instead of a constitutively expressing one. This includes light-inducible systems, which have already 
been used to drive the SunTag system in human cells (Polstein & Gersbach, 2015). Heat-shock 
promoters such as the barley (Hordeum vulgare) HVHSP17 promoter (Freeman et al., 2011) could also 
be used. Tissue-specific promoters could be used, such as the sedoheptulose-1,7-bisphosphatase 
(SBPase) promoter from Brachypodium distachyon, which has been shown to express genes 
specifically in wheat leaf tissue (Alotaibi et al., 2018). These strategies may reduce the already very 
low level of SunTag construct expression and limit the upregulation possible even further. On the 
other hand, by only expressing the SunTag constructs when necessary, any deleterious effects of the 
constructs may be limited.  
In the long-term, to create the most flexible system possible, ‘CRISPRa-ready’ crops could be created. 
This idea has been proposed by Hickey et al. (2019) for Cas9-editing, however, the same theory could 
be applied to dCas9 expression manipulation. This would involve generating plants which stably 
express the dCas9-SunTagx10 and VP64-ScFv constructs. These ‘CRISPRa-ready’ lines could then be 
transformed with sgRNAs and upregulation of any target could be quickly achieved. If more flexibility 
was necessary, the lines could only include the dCas9-SunTagx10 construct, and an ScFv with any 
effector domain could be used to transform the plant; for instance, gene expression downregulators 
could be used, or epigenetic modifiers such as TET1.   
5.4 APPLICATIONS OF CRISPRa IN WHEAT 
Applying this CRISPRa technique in commercial crops would encounter issues regarding regulation in 
the European Union (EU). In 2018 the Court of Justice of the EU ruled that gene editing is subject to 
the same restrictions that apply to genetically modified organisms (GMOs) 
(Court of Justice of the European Union, 2018), which are very restrictive; no GMO varieties are 
commercially grown in the United Kingdom (United Kingdom Government, 2019). This policy is likely 





(1st January 2021) when the UK may stop following EU legislation on GMOs. In the United States, 
although Cas9-edited crops are not regulated if they “could otherwise have been developed through 
traditional breeding techniques” (United States Department of Agriculture Animal and Plant Health 
Inspection Service, 2012), the CRISPRa system described in this study would require regulatory 
approval as the plants are stably transformed with foreign genes. Therefore, under current regulatory 
conditions, the commercial potential of this CRISPRa technique in at least two major markets (the EU 
and the United States) is limited. However, there is the potential of using GM-free techniques such as 
ribonucleoproteins (RNPs) (complexes of RNA and RNA-binding proteins) for short term manipulation 
of gene expression. This technique would involve inserting complete complexes consisting of a 
dCas9-SunTagx10 protein, ten VP64-ScFv proteins, and an sgRNA. These complexes would then directly 
upregulate target genes. This transient technique could theoretically be used without requiring 
stringent regulation, with the advantage of a lower level of off-target activity (Liang et al., 2017). RNPs 
have been successfully used in wheat for basic CRISPR-Cas9 editing (Liang et al., 2017). A possible 
application of this method of short-term upregulation of specific genes would be during droughts to 
increase crop drought tolerance, meaning that any disadvantages imposed by the increased tolerance, 
such as yield decreases, are minimised.  
The greatest current potential of the CRISPRa system is as a research tool. As stated in section 1.2, 
CRISPRa can be used in gain-of-function studies as well as overexpression screens (Konermann et al., 
2015), which would be extremely valuable in fundamental wheat research. Studies using CRISPRa 
could be used to identify candidate alleles for conventional breeding, allowing the technology to 
directly benefit commercial crop development.   
5.4 CONCLUSIONS 
The development of a new tool for wheat research and breeding provides a boost to the global effort 
to increase yields to match increasing global demand. This study’s aim was to translate a technique 
developed in model organisms into a crop species. No CRISPRa system has so far been implemented 
in wheat. The SunTag system is a second-generation technique which has been shown to be more 
effective than dCas9-VP64 in previous studies (Tanenbaum et al., 2014).  
In this study, it has been shown that the components of the SunTag CRISPRa system can be expressed 
in wheat. It has also been shown to be capable of upregulation through a positive-feedback pathway. 
However, for the endogenous gene the system was tested on, no increase in expression was detected. 
Although this may be due to the specific gene targeted, this result suggests that a significant amount 
of further work would be needed to optimise this system for use in wheat for it to become a useful 





TAD copies using different techniques (such as sgRNA 2.0 (Konermann et al., 2015)). There is also the 
potential of improving the flexibility of CRISPRa by using specific or inducible promoters, or through 
the development of a ‘CRISPRa-ready’ wheat line.  
This project achieved almost all the aims as set out in section 1.7. Unfortunately, the results of this 
study mean that it falls short of proving the concept works in wheat. However, it does show that there 
is potential for this system to function in this important crop species and become a useful tool for 
researchers and breeders alike. Improving the tools used for crop development is a vital part of the 
solution to global food insecurity. Increasing wheat yields is of particular significance, as it is the most 
widely grown crop globally and is a staple crop particularly in the developing world (Shiferaw et al., 
2013). With further development, CRISPRa could provide another tool with which to tackle global food 
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A.1 PLASMID MAPS 
 
  
Figure A.1: Map of the GFP reporter plasmid used as a positive control during protoplasting 







Figure A.2: Map of the dCas9-SunTagx10 plasmid used for transient protoplast 







Figure A.3: Map of the dCas9-SunTagx10 plasmid used for stable biolistic transformation. 







Figure A.4: Map of the VP64-ScFv plasmid used for both transient protoplast transformation 





A.2 CONSTRUCT SEQUENCES 




















































































































































































































































































































































































































































A.3 ANTIBODIES, PRIMERS AND sgRNAS 
 
 
Antibody Name Peptide Raised Against 
Antigen Position on dCas9-SunTagx10 Protein 
(amino acid number) 
Cas9 1 CTNFDKNLPNEKVLP 583-596 
Cas9 2 CGFSKESILPKRNSD 1191-1204 
Cas9 3 KVPSKKFKVLGNTDC 113-126 
 
 
Table A.1: Details of the antibodies used throughout this study. All antibodies were from 








Target Gene Oligo Sequence 
Target Sequence Position (0 = 
estimated transcription start 
site) 
Ub 1 Maize ubi1 GCGAACCAGCAGCGTCGCGT -258 
Ub 2 Maize ubi1 GCCAAGCGAAGCAGACGGCA -235 
Ub 3 Maize ubi1 GTCGGCATCCAGAAATTGCG -148 
Ub 4 Maize ubi1 GCGGCAGACGTGAGCCGGCA -121 
PPD 1 Wheat Ppd-D1 GTCCTCCTCCTCCACCTGAC +68 
PPD 2 Wheat Ppd-D1 GCTCTGTTCCTGCTCGATTG +137 
PPD 3 Wheat Ppd-D1 GCCGCCGGCCGCTCCATTCG +315 
PPD 4 Wheat Ppd-D1 GGGACTCCCGGATGCGACCG +452 
PPD 5 Wheat Ppd-D1 GACCCCAACATGTTTCCTCT +552 
 
 
Primer Name Sequence 
Ub (F) CCAACCTCGTGTTGTTCGGAG 
ARF (F) GGCTCTCCAACAACATTGCCAAC 
H2B (R) CAGACACAGCATGTTTCGCCAACTC 
dCas9 (R) ATGGAGTGCCTGTCGGTGTTG 
VP64-ScFv (R) CCGAGACTGCGCAGCTGAG 
ARF (R) GGCTTCTGCCTGTCACATACGC 
Table A.2: Details of the sgRNAs used throughout this study, as supplied by Professor Keith 
Edwards (University of Bristol; Bristol, UK). All sgRNA sequences were used as part of Btg21 
constructs ligated into pUC19 cloning vectors. 
Table A.3: Details of the primers used throughout this study. All primers were from 






A.4 MASS SPECTROMETRY PARAMETERS 
• Mode: data-dependent acquisition 
• Survey scan resolution: 60 000 at m/z 400 
− Mass range: m/z 300-2000 
• Charge state filtering: enabled 
• Dynamic exclusion: enabled 
− Repeat duration: 30 s 
− Repeat count: 1 
− Exclusion list size: 500 
• Fragmentation conditions 
− Normalized collision energy: 40% 
− Activation q: 0.25 
− Activation time: 10 ms 
− Minimum ion selection intensity: 500 counts 
The top 20 multiply charged ions in each duty cycle were used in the LTQ linear ion trap for MS/MS. 
A.5 PROTEOME DISCOVERER PARAMETERS 
• Peptide precursor mass tolerance: 10 ppm 
• MS/MS tolerance: 0.8 Da 
• Mode: full tryptic digestion 
• Maximum number of missed cleavages: 2 
• Reverse database search: enabled 
• False discovery rate cut off: 1% 
A.6 STAR PARAMETERS 
• outFilterScoreMinOverLread: 0.1 
• outFilterMatchNminOverLread: 0.1 
• outSAMtype: BAM Sorted by coordinate 
• runThreadN: 100 
A.7 FEATURECOUNTS PARAMETERS 
• p (isPairedEnd): enabled 





• s (isStrandSpecific): 2 (reversely stranded) 
A.8 RNA-SEQ SUMMARY DATA 


















A.9 ADDITIONAL FLUORESCENT MICROSCOPY IMAGES 
 
 Figure A.5: Fluorescent microscopy images of wheat protoplasts. The protoplasts were 
incubated for approximately 25 h post transformation. Excitation: 470 nm; excitation intensity: 
20%; magnification: 10x. The protoplast treatments are detailed on the left-hand-side of the 
images. Images A-C are of negative control protoplasts (water replaced any transformation 
plasmid). Images D-F are of protoplasts transformed with the GFP control plasmid. Images G-I 
are of protoplasts transformed with the dCas9-SunTagx10 plasmid. Images J-L are of protoplasts 
transformed with the VP64-ScFv plasmid. The filter cubes used are detailed above the images. 
Images A, D, G and J were taken using a brightfield filter cube. Images B, E, H and K were taken 
using a GFP filter cube. Images C, F, I and L were taken using a BGR filter cube.  
